<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02019264</url>
  </required_header>
  <id_info>
    <org_study_id>APD356-G000-401</org_study_id>
    <secondary_id>2013-000324-34</secondary_id>
    <nct_id>NCT02019264</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors</brief_title>
  <acronym>CAMELLIA-TIMI</acronym>
  <official_title>A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eisai Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Eisai Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study in
      overweight and obese subjects with cardiovascular (CV) disease and/or multiple CV risk
      factors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately 12,000 subjects will be randomized to two treatment groups in a ratio of 1:1,
      stratified by the presence of established CV disease (approximately 80%) or CV risk factors
      without established CV disease (approximately 20%). Subjects will receive lorcaserin HCl 10
      mg BID or placebo BID. The study will consist of 2 phases: Prerandomization and
      Randomization. The Prerandomization Phase will last up to 30 days and consist of one visit
      during which subjects will be screened for eligibility. The Randomization Phase will consist
      of two periods: Treatment and Follow-up. The Treatment Period will last for approximately 5
      years with approximately 18 visits and Follow-up period is 30 (+ or - 10 days) from the end
      of treatment visit.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 24, 2014</start_date>
  <completion_date type="Actual">May 14, 2018</completion_date>
  <primary_completion_date type="Actual">May 14, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time From Randomization to First Occurrence of Major Adverse Cardiovascular Events (MACE) at Interim Analysis</measure>
    <time_frame>Baseline up to Month 42</time_frame>
    <description>The MACE events involved myocardial infarction (MI), stroke, or cardiovascular (CV) death. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time From Randomization to First Occurrence of MACE+</measure>
    <time_frame>Baseline up to end of study (Month 56)</time_frame>
    <description>The MACE+ events involved MI, stroke, or CV death or hospitalization for unstable angina or heart failure (HF), or any coronary revascularization. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time From Randomization to Conversion to Type 2 Diabetes Mellitus (T2DM) for Participants With Prediabetes at Baseline</measure>
    <time_frame>Baseline up to end of study (Month 56)</time_frame>
    <description>Time from randomization to conversion to T2DM was defined as first occurrence of any component of the 2013 American Diabetes Association (ADA) Diagnostic Criteria (ADA, 2013) in participants with prediabetes at baseline. The diagnostic criteria were met if a participant had unequivocal hyperglycemia (random plasma glucose greater than or equal to (&gt;=) 200 milligram per deciliter (mg/dL) (11.1 millimole per liter [mmol/L]) with classic symptoms of hyperglycemia or hyperglycemic crisis) or any of the following criteria were observed and subsequently confirmed on repeat laboratory testing such as: glycosylated hemoglobin (HbA1c) &gt;=to 6.5%; fasting plasma glucose (FPG) &gt;=126 mg/dL (7.0 mmol/L); 2-hour plasma glucose &gt;=200 mg/dL (11.1 mmol/L) by an oral glucose tolerance test (OGTT). The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time From Randomization to First Occurrence of the Individual Components of MACE+</measure>
    <time_frame>Baseline up to end of study (Month 56)</time_frame>
    <description>The MACE+ events involved MI, stroke, or CV death or hospitalization for unstable angina or HF, or any coronary revascularization. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time From Randomization to Event of All-cause Mortality</measure>
    <time_frame>Baseline up to end of study (Month 56)</time_frame>
    <description>The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time From Randomization to Conversion to Normal Glucose Homeostasis in Participants With Prediabetes at Baseline</measure>
    <time_frame>Baseline up to end of study (Month 56)</time_frame>
    <description>Normal glucose homeostasis was defined as HbA1c less than or equal to (&lt;=) 5.6% and FPG &lt; 100 mg/dL without any antidiabetic treatment. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time From Randomization to Conversion to T2DM for Participants Without Any Type of Diabetes at Baseline</measure>
    <time_frame>Baseline up to end of study (Month 56)</time_frame>
    <description>The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in HbA1c at Month 6 in Participants With T2DM at Baseline</measure>
    <time_frame>Baseline, and Month 6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time From Randomization to Event of New Onset Renal Impairment or Worsening Existing Renal Impairment in All Participants</measure>
    <time_frame>Baseline up to end of study (Month 56)</time_frame>
    <description>New onset/worsening of existing renal impairment was first occurrence of any events: microalbuminuria and macroalbuminuria (albumin-to-creatinine ratio [ACR] &gt;=30mcg/mg and ACR&gt;=300 mcg/mg in spot urine), worsening albuminuria (microalbuminuria at Baseline developed macroalbuminuria, ACR increased &gt;=30% from Baseline during treatment), newly developed chronic kidney disease (CKD) (eGFR &gt;=90 milliliter per minute per 1.73 [mL/min/1.73]body surface area (BSA) and without kidney damage at Baseline changed to CKD Stage 1/higher as per National Kidney Foundation [NKF] Guidelines [2002]) or worsening of CKD (CKD Stage 1/higher as per NKF Guidelines [2002] worsened to higher CKD stages during treatment), or doubling of serum creatinine (creatinine value at least 2 times Baseline value and &gt;=1.5 mg/dL during treatment.), or any of the following: end-stage renal disease, renal transplant, renal death. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time From Randomization to Event of New Onset Renal Impairment or Worsening Existing Renal Impairment in Participants With Prediabetes at Baseline</measure>
    <time_frame>Baseline up to end of study (Month 56)</time_frame>
    <description>New onset/worsening of existing renal impairment was first occurrence of any events: microalbuminuria and macroalbuminuria (ACR &gt;=30mcg/mg and ACR &gt;=300 mcg/mg in spot urine), worsening albuminuria (microalbuminuria at baseline developed macroalbuminuria, ACR increased &gt;=30% from baseline during treatment), CKD (eGFR &gt;=90 mL/min/1.73 BSA and without kidney damage at baseline changed to CKD Stage 1/higher as per NKF Guidelines [2002]) or worsening of CKD (CKD Stage 1/higher as per NKF Guidelines [2002] worsened to higher CKD stages during treatment), or doubling of serum creatinine (creatinine value at least 2 times baseline value and &gt;=1.5 mg/dL during treatment.), or any of the following: end-stage renal disease, renal transplant, renal death. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time From Randomization to Event of New Onset Renal Impairment or Worsening Existing Renal Impairment in Participants With T2DM at Baseline</measure>
    <time_frame>Baseline up to end of study (Month 56)</time_frame>
    <description>New onset/worsening of existing renal impairment was first occurrence of any events: microalbuminuria and macroalbuminuria (ACR &gt;=30 mcg/mg and ACR &gt;=300 mcg/mg in spot urine), worsening albuminuria (microalbuminuria at baseline developed macroalbuminuria, ACR increased &gt;=30% from baseline during treatment), CKD (eGFR &gt;=90 mL/min/1.73 BSA and without kidney damage at baseline changed to CKD Stage 1/higher as per NKF Guidelines [2002]) or worsening of CKD (CKD Stage 1/higher as per NKF Guidelines [2002] worsened to higher CKD stages during treatment), or doubling of serum creatinine (creatinine value at least 2 times baseline value and &gt;=1.5 mg/dL during treatment.), or any of the following: end-stage renal disease, renal transplant, renal death. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time From Randomization to Event of Improvement in Renal Function in Participants With T2DM at Baseline</measure>
    <time_frame>Baseline up to end of study (Month 56)</time_frame>
    <description>Improvement in renal function was defined as first occurrence of regression of albuminuria or regression of CKD. Regression of albuminuria was defined as when participants with macroalbuminuria at baseline developed microalbuminuria or nonalbuminuria (ACR &lt;30 mcg/mg in spot urine), or participants with microalbuminuria at baseline became nonalbuminuric, and ACR value decreased &gt;= 30% from previous assessment during treatment. Regression of CKD defined as when participants with CKD Stage 1 or higher at baseline improved to normal or lower stages by NKF guidelines (eGFR &gt;=90 with albuminuria at baseline improved to eGFR &gt;=90 without albuminuria, or eGFR 60 to 89 at baseline became eGFR &gt;=90 with or without albuminuria, or eGFR between 30 to 59 at baseline improved to &gt;60 mL/min/1.73 BSA) during treatment. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Met FDA-Defined Valvulopathy in Echocardiographically Determined Heart Valve Changes</measure>
    <time_frame>Months 6 and 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With FDA-Defined Valvulopathy at Baseline Who Demonstrated Worsened FDA-Defined Valvulopathy</measure>
    <time_frame>Months 6 and 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Echocardiographically-Determined Pulmonary Arterial Systolic Pressure</measure>
    <time_frame>Baseline, Month 12</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14673</enrollment>
  <condition>Cardiovascular Disease</condition>
  <condition>High Cardiovascular Risk</condition>
  <condition>Obesity</condition>
  <condition>Overweight</condition>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Lorcaserin hydrochloride (HCL)10 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>APD356 10 mg twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo twice daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lorcaserin hydrochloride</intervention_name>
    <description>APD356 10 mg twice daily</description>
    <arm_group_label>Lorcaserin hydrochloride (HCL)10 mg</arm_group_label>
    <other_name>APD356</other_name>
    <other_name>BELVIQ</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo twice daily</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          1. BMI greater than or equal (&gt;=) to 27 kilogram per meter square (kg/m^2)

          2. Subjects able and willing to comply with a reduced-calorie diet and an increased
             physical activity program

          3. Age &gt;= to 40 years with established CV disease as defined by one of the following:

               1. History of documented MI or ischemic stroke

               2. History of peripheral artery disease

               3. History of revascularization (coronary, carotid, or peripheral artery)

               4. Significant unrevascularized coronary arterial stenosis

        OR

        Age &gt;= to 55 years for women or &gt;= to 50 years for men who have type 2 diabetes mellitus
        (T2DM) without established CV disease plus at least one of the following CV risk factors:

          1. Hypertension, or currently receiving therapy for documented hypertension

          2. Dyslipidemia, or currently taking prescription lipid-lowering therapy for documented
             dyslipidemia

          3. Estimated glomerular filtration rate &gt;= to 30 to less than equal (&lt;=) to 60 mililitre
             per minute per 1.73 meter square (mL/min/1.73 m^) per the Chronic Kidney Disease
             Epidemiology Collaboration (CKD-EPI) equation

          4. High high sensitivity C-reactive protein (hsCRP)

          5. Urinary albumin-to-creatinine ratio (ACR) &gt;= 30 ug/mg

        Subjects with T2DM may have a pre-existing or new diagnosis of T2DM. A new diagnosis of
        T2DM (ie, discovered at Screening) should be based on the 2013 American Diabetes
        Association (ADA) guidelines.

        All T2DM subjects must have an HbA[1c] less (&lt;) than 10% at Screening. If subjects are
        being treated, or upon diagnosis need to be treated with antidiabetic agents, the T2DM
        treatment regimen must be stable for at least 3 months prior to randomization.

        Exclusion Criteria

          1. Moderate or greater symptoms of congestive cardiac failure (New York Heart Association
             [NYHA] class III or IV)

          2. Known left ventricular (LV) ejection fraction &lt; than 20%

          3. Moderate or greater symptoms of pulmonary hypertension (PH)

          4. Known severe valvular disease

          5. Moderate renal impairment, severe renal impairment (estimated glomerular filtration
             rate &lt; 30 mL/min/1.73 m^ per the CKD-EPI equation based on ideal body weight), or end
             stage renal disease (ESRD)

          6. Severe hepatic impairment

          7. Use of other products intended for weight loss including prescription drugs,
             over-the-counter (OTC) drugs, and herbal preparations

          8. Use of more than one other serotonergic drug

          9. Use of drugs known to increase the risk for cardiac valvulopathy within 6 months prior
             to Screening including, but not limited to: pergolide, ergotamine, methysergide,
             cabergoline

         10. History or evidence of clinically significant disease (e.g., malignancy, cardiac,
             respiratory, gastrointestinal, renal or psychiatric disease)

         11. Use of lorcaserin HCl prior to Screening or hypersensitivity to lorcaserin HCl or any
             of the excipients

         12. Planned bariatric surgery

         13. Females must not be breastfeeding or pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Advanced Cardiovascular, LLC</name>
      <address>
        <city>Alexander City</city>
        <state>Alabama</state>
        <zip>35010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Alabama Research Center, LLC</name>
      <address>
        <city>Athens</city>
        <state>Alabama</state>
        <zip>35611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UAB Medical Center</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coastal Clinical Research, Inc.</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mobile Heart Specialists, PC</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alaska Heart Institute</name>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <zip>99508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Connect Clinical Research Center, LCC</name>
      <address>
        <city>Chandler</city>
        <state>Arizona</state>
        <zip>85224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arrowhead Health Centers</name>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <zip>85306</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phoenix Heart, PLLC</name>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <zip>85306</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eclipse Clinical Research</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85745</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NEA Baptist Clinic</name>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <zip>72401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arkansas Cardiology Clinic</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Arkansas Veterans Healthcare System</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Preferred Research Partners</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research Alliance</name>
      <address>
        <city>Alhambra</city>
        <state>California</state>
        <zip>91801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Cardiology</name>
      <address>
        <city>Bakersfield</city>
        <state>California</state>
        <zip>93308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Research Foundation of Southern Cal</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capitol Interventional Cardiology</name>
      <address>
        <city>Carmichael</city>
        <state>California</state>
        <zip>95608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Diego Costal Endocrinology Group AMC</name>
      <address>
        <city>Chula Vista</city>
        <state>California</state>
        <zip>91911 3813</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Muir Physician Network Clinical Research Cent</name>
      <address>
        <city>Concord</city>
        <state>California</state>
        <zip>94520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Group of Encino</name>
      <address>
        <city>Encino</city>
        <state>California</state>
        <zip>91436</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marin Endocrine Care &amp; Research, Inc.</name>
      <address>
        <city>Greenbrae</city>
        <state>California</state>
        <zip>94904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>California Heart Specialists</name>
      <address>
        <city>Huntington Beach</city>
        <state>California</state>
        <zip>92648</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Del Rosario Medical Clinic, Inc.</name>
      <address>
        <city>Huntington Park</city>
        <state>California</state>
        <zip>90255</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diabetes and Endocrine Associates</name>
      <address>
        <city>La Mesa</city>
        <state>California</state>
        <zip>91942</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>La Mesa Cardiac Center</name>
      <address>
        <city>La Mesa</city>
        <state>California</state>
        <zip>91942</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alliance Research Centers</name>
      <address>
        <city>Laguna Hills</city>
        <state>California</state>
        <zip>92653</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Torrance Clinical Research Institute, Inc.</name>
      <address>
        <city>Lomita</city>
        <state>California</state>
        <zip>90717</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Long Beach Center for Clinical Research</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Metabolic Clinic and Research Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beverly Hills Cardiology</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90067</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Greater Los Angeles Health Care System</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Interventions Research Institute</name>
      <address>
        <city>Mission Viejo</city>
        <state>California</state>
        <zip>92692</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigid Freyne MD Inc</name>
      <address>
        <city>Murrieta</city>
        <state>California</state>
        <zip>92563</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valley Clinical Trials Inc</name>
      <address>
        <city>Northridge</city>
        <state>California</state>
        <zip>91325</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carr Cardiology</name>
      <address>
        <city>Oceanside</city>
        <state>California</state>
        <zip>92056</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northern California Clinical Research Center</name>
      <address>
        <city>Redding</city>
        <state>California</state>
        <zip>96001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sharp Rees-Stealy Medical Group, Inc.</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ritchken and First MD's</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Coast Research LLC</name>
      <address>
        <city>San Ramon</city>
        <state>California</state>
        <zip>94582</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coastal Multi-Specialty Research</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <zip>92704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westlake Medical Research</name>
      <address>
        <city>Thousand Oaks</city>
        <state>California</state>
        <zip>91360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harbor - UCLA Medical Center</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90509</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ronald Chochinov, MD</name>
      <address>
        <city>Ventura</city>
        <state>California</state>
        <zip>93003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ventura Cardiology Consultants</name>
      <address>
        <city>Ventura</city>
        <state>California</state>
        <zip>93003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Infosphere Clinical Research</name>
      <address>
        <city>West Hills</city>
        <state>California</state>
        <zip>91307</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCH-MHS Cardiac Research</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80909</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Creekside Endocrine Associates PC</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New West Physicians, PC</name>
      <address>
        <city>Golden</city>
        <state>Colorado</state>
        <zip>80401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Health</name>
      <address>
        <city>Loveland</city>
        <state>Colorado</state>
        <zip>80538</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Connecticut Clinical Research, LLC</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <zip>06606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bridgeport Hospital</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <zip>06610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research Works, Bristol</name>
      <address>
        <city>Bristol</city>
        <state>Connecticut</state>
        <zip>06010-5103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates of Fairfield County, Norwalk</name>
      <address>
        <city>Norwalk</city>
        <state>Connecticut</state>
        <zip>06851</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates of Fairfield County, P.C.</name>
      <address>
        <city>Stamford</city>
        <state>Connecticut</state>
        <zip>06905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stamford Therapeutics Consortium</name>
      <address>
        <city>Stamford</city>
        <state>Connecticut</state>
        <zip>06905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates of Fairfield County, P.C.</name>
      <address>
        <city>Trumbull</city>
        <state>Connecticut</state>
        <zip>06611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Connecticut Heart and Vascular Center</name>
      <address>
        <city>Trumbull</city>
        <state>Connecticut</state>
        <zip>06611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chase Medical Research, LLC</name>
      <address>
        <city>Waterbury</city>
        <state>Connecticut</state>
        <zip>06708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Red Clay Research</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alfieri Cardiology</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803-3733</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aventura Heart Center</name>
      <address>
        <city>Aventura</city>
        <state>Florida</state>
        <zip>33180</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zasa Clinical Research</name>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <zip>33427</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meridien Research</name>
      <address>
        <city>Bradenton</city>
        <state>Florida</state>
        <zip>34201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NOVA Southeastern University</name>
      <address>
        <city>Bradenton</city>
        <state>Florida</state>
        <zip>34209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bay Area Cardiology</name>
      <address>
        <city>Brandon</city>
        <state>Florida</state>
        <zip>33511</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meridien Research, Brooksville</name>
      <address>
        <city>Brooksville</city>
        <state>Florida</state>
        <zip>34601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clearwater Cardiovascular and Interventional Cons.</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research of South Florida</name>
      <address>
        <city>Coral Gables</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holy Cross Medical Group</name>
      <address>
        <city>Coral Springs</city>
        <state>Florida</state>
        <zip>33065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Research Associates</name>
      <address>
        <city>Daytona Beach</city>
        <state>Florida</state>
        <zip>32117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>International Medical Research</name>
      <address>
        <city>Daytona Beach</city>
        <state>Florida</state>
        <zip>32117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asclepius Medical Research</name>
      <address>
        <city>Doral</city>
        <state>Florida</state>
        <zip>33166</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fleming Island Center for Clinical Research</name>
      <address>
        <city>Fleming Island</city>
        <state>Florida</state>
        <zip>32003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Integrative Research Associates, Inc.</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33312</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>M &amp; O Clinical Research, LLC</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33316</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Primary Care Associates</name>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <zip>33907</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Research Network, LLC</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>George E. Platt, M.D.</name>
      <address>
        <city>Green Cove Springs</city>
        <state>Florida</state>
        <zip>32043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastern Research, Inc.</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Larry K. Levinson, D.O., P.A.</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <zip>33021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Physicians Network Alliance</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <zip>33021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pasco Cardiology Center</name>
      <address>
        <city>Hudson</city>
        <state>Florida</state>
        <zip>34667</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nature Coast Clinical Research</name>
      <address>
        <city>Inverness</city>
        <state>Florida</state>
        <zip>34452</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida- Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jacksonville Center for Clinical Research</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westside Center for Clinical Research</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meridien Research</name>
      <address>
        <city>Lakeland</city>
        <state>Florida</state>
        <zip>33805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pharmax Research Clinic, Inc</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33126-2956</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Life Spring Research Foundation</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>United Clinical Research Corp.</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33155</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Research Center of South Florida</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33173</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Florida Research Group LLC</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Florida Research Solutions</name>
      <address>
        <city>Miramar</city>
        <state>Florida</state>
        <zip>33025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southwest Florida Research</name>
      <address>
        <city>Naples</city>
        <state>Florida</state>
        <zip>34102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ocala Research Institute, Inc</name>
      <address>
        <city>Ocala</city>
        <state>Florida</state>
        <zip>34471</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oviedo Medical Research</name>
      <address>
        <city>Oviedo</city>
        <state>Florida</state>
        <zip>32765</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Partners Clinical Research Institute</name>
      <address>
        <city>Palm Beach Gardens</city>
        <state>Florida</state>
        <zip>33410-4304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Palm Beach Gardens Research Center</name>
      <address>
        <city>Palm Beach Gardens</city>
        <state>Florida</state>
        <zip>33410</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Physicians Network Alliance, Pembrok</name>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <zip>33025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Florida Research Solutions</name>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <zip>33028</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Consultants</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32501 6335</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research of Central Florida</name>
      <address>
        <city>Plant City</city>
        <state>Florida</state>
        <zip>33563</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia Primary Care, LLC d/b/a Heart and Health Institute</name>
      <address>
        <city>Plantation</city>
        <state>Florida</state>
        <zip>33324</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Johns Center for Clinical Research</name>
      <address>
        <city>Ponte Vedra</city>
        <state>Florida</state>
        <zip>32081</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charlotte Heart Group Research Center</name>
      <address>
        <city>Port Charlotte</city>
        <state>Florida</state>
        <zip>33952</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Progressive Medical Research</name>
      <address>
        <city>Port Orange</city>
        <state>Florida</state>
        <zip>32127</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brevard Cardiovascular Research Associates Inc</name>
      <address>
        <city>Rockledge</city>
        <state>Florida</state>
        <zip>32955</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clearwater Cardiovascular and Interventional Cons.</name>
      <address>
        <city>Safety Harbor</city>
        <state>Florida</state>
        <zip>34695</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bayfront Health St. Petersburg, Research</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meridien Research - St. Petersburg</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33709</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Professional Health Care of Pinellas, INC</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Intercoastal Medical Group</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Springfield Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Florida</state>
        <zip>32401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Clinical Research Group</name>
      <address>
        <city>Stuart</city>
        <state>Florida</state>
        <zip>34996</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meridien Research - Tampa</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stedman Clinical Trials</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Healthpoint Medical Group, Inc</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Interventional Cardiac Consultants</name>
      <address>
        <city>Trinity</city>
        <state>Florida</state>
        <zip>34655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lovelace Scientific Research</name>
      <address>
        <city>Venice</city>
        <state>Florida</state>
        <zip>34292</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indian River Medical Center-Cardiology</name>
      <address>
        <city>Vero Beach</city>
        <state>Florida</state>
        <zip>32960-3296</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Partners Clinical Research Institute</name>
      <address>
        <city>Wellington</city>
        <state>Florida</state>
        <zip>33449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Metabolic Research Institute</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research of Central Florida</name>
      <address>
        <city>Winter Haven</city>
        <state>Florida</state>
        <zip>33880</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Atlanta Diabetes Associates, Endocrinology</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30318</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rockdale Medical-Research Associates</name>
      <address>
        <city>Conyers</city>
        <state>Georgia</state>
        <zip>30094</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Atlanta Heart Specialists</name>
      <address>
        <city>Cumming</city>
        <state>Georgia</state>
        <zip>30041</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Urban Family Practice Associates/Clinical Research Advantage</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30067</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Endocrine Research Solutions, Inc.</name>
      <address>
        <city>Roswell</city>
        <state>Georgia</state>
        <zip>30076</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herman Clinical Research LLC</name>
      <address>
        <city>Suwanee</city>
        <state>Georgia</state>
        <zip>30024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Atlanta Heart Specialists</name>
      <address>
        <city>Tucker</city>
        <state>Georgia</state>
        <zip>30084</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Heart Clinical Research, LLC</name>
      <address>
        <city>Arlington Heights</city>
        <state>Illinois</state>
        <zip>60005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cedar-Crosse Research Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University Feinberg School of Medicine</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Consultants in Cardiovascular Medicine</name>
      <address>
        <city>Elmhurst</city>
        <state>Illinois</state>
        <zip>60126</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Investigation Specialists, Inc. in Gurnee</name>
      <address>
        <city>Gurnee</city>
        <state>Illinois</state>
        <zip>60031</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced CardioVascular Consultants, SC</name>
      <address>
        <city>Rock Island</city>
        <state>Illinois</state>
        <zip>61201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Clinical Research Center</name>
      <address>
        <city>Anderson</city>
        <state>Indiana</state>
        <zip>46011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>American Health Network of IN, LLC, Avon</name>
      <address>
        <city>Avon</city>
        <state>Indiana</state>
        <zip>46123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Premier Healthcare, LLC</name>
      <address>
        <city>Bloomington</city>
        <state>Indiana</state>
        <zip>47403 3239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deaconess Clinic, Inc.</name>
      <address>
        <city>Evansville</city>
        <state>Indiana</state>
        <zip>47713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>American Health Network of IN, LLC, Franklin</name>
      <address>
        <city>Franklin</city>
        <state>Indiana</state>
        <zip>46131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>American Health Network of IN, LLC, Greenfield</name>
      <address>
        <city>Greenfield</city>
        <state>Indiana</state>
        <zip>46140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>American Health Network - Thomas Moretto, MD</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46254-5471</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Consultants PC</name>
      <address>
        <city>Muncie</city>
        <state>Indiana</state>
        <zip>47303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>American Health Network of IN, LLC</name>
      <address>
        <city>Muncie</city>
        <state>Indiana</state>
        <zip>47304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates of Northwest Indiana, P.C</name>
      <address>
        <city>Munster</city>
        <state>Indiana</state>
        <zip>46321</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The University of Iowa, College of Public Health</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Professional Research Network of Kansas, LLC</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norton Heart Specialists</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40205 3338</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norton Heart Specialists</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40205-3338</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>L-MARC Research Center</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Integrity LLC</name>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <zip>42303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Maine Medical Center</name>
      <address>
        <city>Auburn</city>
        <state>Maine</state>
        <zip>04210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Acadia Clinical Research, LLC</name>
      <address>
        <city>Bangor</city>
        <state>Maine</state>
        <zip>04401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastern Maine Medical Center Northeast Cardiology Associates</name>
      <address>
        <city>Bangor</city>
        <state>Maine</state>
        <zip>04401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern Maine Health Care/Maine Medical Center Research Ins</name>
      <address>
        <city>Biddeford</city>
        <state>Maine</state>
        <zip>04005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>InterMed, PA</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medstar Cardiology Associates</name>
      <address>
        <city>Annapolis</city>
        <state>Maryland</state>
        <zip>21401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chesapeake Cardiovascular Associates, GBMC</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research, Inc</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medstar Union Memorial Heart Specialists</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medstar Union Memorial Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spectrum Clinical Research</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Overlea Personal Physicians</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shahid Saeed MD, PC</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21237</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maryland Heart Associates, LLC</name>
      <address>
        <city>Glen Burnie</city>
        <state>Maryland</state>
        <zip>21061</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klein &amp; Associates, MD, PA</name>
      <address>
        <city>Hagerstown</city>
        <state>Maryland</state>
        <zip>21740</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedStar Health Research Institute</name>
      <address>
        <city>Hyattsville</city>
        <state>Maryland</state>
        <zip>20782</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lutherville Personal Physicians</name>
      <address>
        <city>Lutherville</city>
        <state>Maryland</state>
        <zip>21093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MD Medical Research</name>
      <address>
        <city>Oxon Hill</city>
        <state>Maryland</state>
        <zip>20745</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Endocrine &amp; Metabolic Consultants</name>
      <address>
        <city>Rockville</city>
        <state>Maryland</state>
        <zip>20852</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lutherville Personal Physicians</name>
      <address>
        <city>Towson</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Overlea Personal Physicians</name>
      <address>
        <city>Towson</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MGH Weight Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New England Center for Clinical Research, IMCA</name>
      <address>
        <city>Fall River</city>
        <state>Massachusetts</state>
        <zip>02720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pentucket Medical Associates</name>
      <address>
        <city>Haverhill</city>
        <state>Massachusetts</state>
        <zip>01830</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ActivMed Practices</name>
      <address>
        <city>Methuen</city>
        <state>Massachusetts</state>
        <zip>01844</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Partners Community Physicians Organization</name>
      <address>
        <city>Natick</city>
        <state>Massachusetts</state>
        <zip>01760</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Partners Community Physicians Organization</name>
      <address>
        <city>Needham</city>
        <state>Massachusetts</state>
        <zip>02494</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Endeavor Medical Research PLC</name>
      <address>
        <city>Alpena</city>
        <state>Michigan</state>
        <zip>49707</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cadillac Clinical Research, LLC</name>
      <address>
        <city>Cadillac</city>
        <state>Michigan</state>
        <zip>49601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westside Family Medical Center, PC</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49009</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Consultants of East Michigan</name>
      <address>
        <city>Lapeer</city>
        <state>Michigan</state>
        <zip>48446</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marquette General Heart and Vascular Institute</name>
      <address>
        <city>Marquette</city>
        <state>Michigan</state>
        <zip>49855</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MidMichigan Medical Center</name>
      <address>
        <city>Midland</city>
        <state>Michigan</state>
        <zip>48670</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nisus Research at McLaren Northern Michigan Hospital</name>
      <address>
        <city>Petoskey</city>
        <state>Michigan</state>
        <zip>49770</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Mercy Oakland Hospital</name>
      <address>
        <city>Pontiac</city>
        <state>Michigan</state>
        <zip>48341-2985</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Remedica LLC</name>
      <address>
        <city>Rochester</city>
        <state>Michigan</state>
        <zip>48307</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michigan CardioVascular Institute</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <zip>48601 1423</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>American Center for Clinical Trials</name>
      <address>
        <city>Southfield</city>
        <state>Michigan</state>
        <zip>48034</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Research Associates, Inc.</name>
      <address>
        <city>Traverse City</city>
        <state>Michigan</state>
        <zip>49684-2386</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michigan Heart</name>
      <address>
        <city>Ypsilanti</city>
        <state>Michigan</state>
        <zip>48197</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minneapolis Heart Institute Foundation</name>
      <address>
        <city>Baxter</city>
        <state>Minnesota</state>
        <zip>56425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Essentia Institute of Rural Health</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MNCOME Clinic</name>
      <address>
        <city>Eagan</city>
        <state>Minnesota</state>
        <zip>55123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiant Research, Inc.</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minneapolis Heart Institute</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regions Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coast Cardiovascular Consultants PLLC</name>
      <address>
        <city>Gulfport</city>
        <state>Mississippi</state>
        <zip>39501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates Research, LLC</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diabetes &amp; Endocrinology Specialists, Inc.</name>
      <address>
        <city>Chesterfield</city>
        <state>Missouri</state>
        <zip>63017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>BodyAesthetic Research Center</name>
      <address>
        <city>Washington</city>
        <state>Missouri</state>
        <zip>63090</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Billings Clinic Research Center</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montana Health Research Institute, Inc.</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glacier View Cardiology PC</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <zip>59901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Internal Medical Associates of Grand Island, PC</name>
      <address>
        <city>Grand Island</city>
        <state>Nebraska</state>
        <zip>68803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research Advantage / Rita Chuang, M.D.</name>
      <address>
        <city>Henderson</city>
        <state>Nevada</state>
        <zip>89052</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research Advantage, Inc.</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research of South Nevada</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medicor Cardiology, PA</name>
      <address>
        <city>Bridgewater</city>
        <state>New Jersey</state>
        <zip>08807-3060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Heart Care</name>
      <address>
        <city>Bridgewater</city>
        <state>New Jersey</state>
        <zip>08807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UmiMed Center LLC</name>
      <address>
        <city>East Brunswick</city>
        <state>New Jersey</state>
        <zip>08816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates of the Delaware Valley</name>
      <address>
        <city>Elmer</city>
        <state>New Jersey</state>
        <zip>08318-1715</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advocare Heights Primary Care</name>
      <address>
        <city>Haddon Heights</city>
        <state>New Jersey</state>
        <zip>08035</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates of the Delaware Valley P</name>
      <address>
        <city>Haddon Heights</city>
        <state>New Jersey</state>
        <zip>08035</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NJ Heart</name>
      <address>
        <city>Linden</city>
        <state>New Jersey</state>
        <zip>07036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rutgers New Jersey Medical School</name>
      <address>
        <city>Mine Hill</city>
        <state>New Jersey</state>
        <zip>07103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates Delaware Valley Sewell</name>
      <address>
        <city>Sewell</city>
        <state>New Jersey</state>
        <zip>08080-1715</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardio Metabolic Institute</name>
      <address>
        <city>Somerset</city>
        <state>New Jersey</state>
        <zip>08873</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Mexico Heart Institute, PA</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albany College of Medicine, Division of Endocrinology</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capital Cardiology Associates</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>United Medical Associates, PC</name>
      <address>
        <city>Binghamton</city>
        <state>New York</state>
        <zip>13901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>James J. Peters VA Medical Center, Bronx, NY</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10468</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Buffalo Heart Group</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Clinical Research, Inc.</name>
      <address>
        <city>Endwell</city>
        <state>New York</state>
        <zip>13760</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Long Island Gastrointestinal Research Group LLP</name>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <zip>11023</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Long Island Heart Associates</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore Diabetes and Endocrine Associates</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DiGiovanna Institute for Medical Education</name>
      <address>
        <city>North Massapequa</city>
        <state>New York</state>
        <zip>11758</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hudson Valley Heart Center</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <zip>12601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rochester Clinical Research, Inc.</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwell Health Physician Partners Cardiology</name>
      <address>
        <city>Southampton</city>
        <state>New York</state>
        <zip>11968</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capital Cardiology Associates</name>
      <address>
        <city>Troy</city>
        <state>New York</state>
        <zip>12180</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Great Lakes Medical Research</name>
      <address>
        <city>Westfield</city>
        <state>New York</state>
        <zip>14787</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kernodle Clinic</name>
      <address>
        <city>Burlington</city>
        <state>North Carolina</state>
        <zip>27215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Trials of America Inc.</name>
      <address>
        <city>Cary</city>
        <state>North Carolina</state>
        <zip>27518</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Metrolina Internal Medicine</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PMG Research of Charlotte, LLC</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bland Clinic, PA</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Trials of America Inc. Hickory</name>
      <address>
        <city>Hickory</city>
        <state>North Carolina</state>
        <zip>28601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Trials of America, Inc.</name>
      <address>
        <city>Hickory</city>
        <state>North Carolina</state>
        <zip>28601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peters Medical Research</name>
      <address>
        <city>High Point</city>
        <state>North Carolina</state>
        <zip>27262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Trials of America, Inc.</name>
      <address>
        <city>Lenoir</city>
        <state>North Carolina</state>
        <zip>28645</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diabetes &amp; Endocrinology Consultants</name>
      <address>
        <city>Morehead City</city>
        <state>North Carolina</state>
        <zip>28557</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Burke Primary Care</name>
      <address>
        <city>Morganton</city>
        <state>North Carolina</state>
        <zip>28655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pinehurst Medical Clinic, Inc.</name>
      <address>
        <city>Pinehurst</city>
        <state>North Carolina</state>
        <zip>28374-8798</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Research Associates, LLC</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PMG Research of Rocky Mount</name>
      <address>
        <city>Rocky Mount</city>
        <state>North Carolina</state>
        <zip>27804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PMG Research of Salisbury</name>
      <address>
        <city>Salisbury</city>
        <state>North Carolina</state>
        <zip>28144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanford Cardiology</name>
      <address>
        <city>Sanford</city>
        <state>North Carolina</state>
        <zip>27330</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Piedmont Healthcare</name>
      <address>
        <city>Statesville</city>
        <state>North Carolina</state>
        <zip>28625</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PMG Research of Wilmington</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PMG Research of Winston-Salem, LLC</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lillestol Research LLC</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aultman Hospital</name>
      <address>
        <city>Canton</city>
        <state>Ohio</state>
        <zip>44710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Lindner Research Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sentral Clinical Research</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Delaware Research Group, LLC</name>
      <address>
        <city>Delaware</city>
        <state>Ohio</state>
        <zip>43015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Awasty Research Network, LLC</name>
      <address>
        <city>Marion</city>
        <state>Ohio</state>
        <zip>43302</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Health Care</name>
      <address>
        <city>Massillon</city>
        <state>Ohio</state>
        <zip>44646</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Apex Medical Research Inc.</name>
      <address>
        <city>Springfield</city>
        <state>Ohio</state>
        <zip>45505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Integris Cardiovascular Physicians LLC</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Clinical Research</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Oklahoma Heart Research, LLC</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oklahoma Heart Institute</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vital Prospects Clinical Research Institute PC</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74136 7028</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Blair Medical Associates</name>
      <address>
        <city>Altoona</city>
        <state>Pennsylvania</state>
        <zip>16602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research Associates of Central PA, LLC</name>
      <address>
        <city>Altoona</city>
        <state>Pennsylvania</state>
        <zip>16602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capital Area Research, LLC</name>
      <address>
        <city>Camp Hill</city>
        <state>Pennsylvania</state>
        <zip>17011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Health Clinic</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Health System</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Doylestown Health Cardiology a Division of Doylestown Health</name>
      <address>
        <city>Doylestown</city>
        <state>Pennsylvania</state>
        <zip>18901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Altoona Center for Clinical Research</name>
      <address>
        <city>Duncansville</city>
        <state>Pennsylvania</state>
        <zip>16635</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Liberty Family Practice</name>
      <address>
        <city>Erie</city>
        <state>Pennsylvania</state>
        <zip>16508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Endocrine Clinical Research LLC</name>
      <address>
        <city>Feasterville</city>
        <state>Pennsylvania</state>
        <zip>19053</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Joseph Lamantia, DO</name>
      <address>
        <city>Indiana</city>
        <state>Pennsylvania</state>
        <zip>15701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Clinical Trial Center, LLC</name>
      <address>
        <city>Jenkintown</city>
        <state>Pennsylvania</state>
        <zip>19046</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lycoming Internal Medicine, Inc.</name>
      <address>
        <city>Jersey Shore</city>
        <state>Pennsylvania</state>
        <zip>17740</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Berkley Hills Clinicals</name>
      <address>
        <city>Johnstown</city>
        <state>Pennsylvania</state>
        <zip>15905-3443</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ilumina Clinical Associates, Johnstown</name>
      <address>
        <city>Johnstown</city>
        <state>Pennsylvania</state>
        <zip>15905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Joseph Lamantia, DO</name>
      <address>
        <city>Johnstown</city>
        <state>Pennsylvania</state>
        <zip>15905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Comprehensive Cardiology Consultants</name>
      <address>
        <city>Langhorne</city>
        <state>Pennsylvania</state>
        <zip>19047</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Detweiler Family Medicine and Associates PC</name>
      <address>
        <city>Lansdale</city>
        <state>Pennsylvania</state>
        <zip>19446</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Green &amp; Seidner Family Practice Associates</name>
      <address>
        <city>Lansdale</city>
        <state>Pennsylvania</state>
        <zip>19446</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capital Area Research LLC</name>
      <address>
        <city>Newport</city>
        <state>Pennsylvania</state>
        <zip>17074</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Endocrine Metabolic Associates</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pottstown Medical Specialists, Inc. (PMSI)</name>
      <address>
        <city>Pottstown</city>
        <state>Pennsylvania</state>
        <zip>19464</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Clinic</name>
      <address>
        <city>Scranton</city>
        <state>Pennsylvania</state>
        <zip>18508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Partners in Clinical Research</name>
      <address>
        <city>Cumberland</city>
        <state>Rhode Island</state>
        <zip>02864</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiant Research, Inc.</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29650</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mountain View Clinical Research</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29651</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Palmetto Research Center, LLC</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29302</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brown Clinic, PLLP</name>
      <address>
        <city>Watertown</city>
        <state>South Dakota</state>
        <zip>57201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PMG Research of Bristol, LLC</name>
      <address>
        <city>Bristol</city>
        <state>Tennessee</state>
        <zip>37620</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chattanooga Research and Medicine (CHARM)</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>WR-ClinSearch, LLC</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37421</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wellmont CVA Heart Institute</name>
      <address>
        <city>Greeneville</city>
        <state>Tennessee</state>
        <zip>37745-5810</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Associates of Jackson</name>
      <address>
        <city>Jackson</city>
        <state>Tennessee</state>
        <zip>38301-3930</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kore Cardiovascular Research</name>
      <address>
        <city>Jackson</city>
        <state>Tennessee</state>
        <zip>38305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Jackson Clinic, PA</name>
      <address>
        <city>Jackson</city>
        <state>Tennessee</state>
        <zip>38305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wellmont CVA Heart Institute</name>
      <address>
        <city>Johnson City</city>
        <state>Tennessee</state>
        <zip>37604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holston Medical Group</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wellmont CVA Heart Institute</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Endocrine Clinic</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38119</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Wellness Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Texas Clinical Research, LLC</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Diabetes &amp; Endocrinology</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78731</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Health Physicians Group</name>
      <address>
        <city>Carrollton</city>
        <state>Texas</state>
        <zip>75007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Adriana Pop-Moody MD Clinic, PA</name>
      <address>
        <city>Corpus Christi</city>
        <state>Texas</state>
        <zip>78404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Research Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Health Physicians Group</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Health Physicians Group, Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Institute of Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Odilon Alvarado, M.D.</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Health Physicians Group Fort Worth</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tand R Clinic, PA</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Gabriel Clinical Research, LLC</name>
      <address>
        <city>Georgetown</city>
        <state>Texas</state>
        <zip>78626</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Angiocardiac Care of Texas PA</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77025 5253</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oxford Clinical Research, LLC</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77074</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Houston Area Clinical Trial Consultants, LLC</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77094</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Endocrine and Psychiatry Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Health Physicians Group</name>
      <address>
        <city>Irving</city>
        <state>Texas</state>
        <zip>75039</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Cardiology Associates of Houston</name>
      <address>
        <city>Kingwood</city>
        <state>Texas</state>
        <zip>77339</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jalil Aziz Khan M.D., P.A.</name>
      <address>
        <city>Lewisville</city>
        <state>Texas</state>
        <zip>75067</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midland Clinical Research Center</name>
      <address>
        <city>Midland</city>
        <state>Texas</state>
        <zip>79707</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Permian Research Foundation</name>
      <address>
        <city>Odessa</city>
        <state>Texas</state>
        <zip>79761</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Clinic of North Texas</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75023</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Investigations of Texas, LLC</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Diabetes</name>
      <address>
        <city>Round Rock</city>
        <state>Texas</state>
        <zip>78681</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Physician PrimeCare Research Institute, PLLC</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78228</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Clinic of San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiant Research San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Martin Diagnostic Clinic</name>
      <address>
        <city>Tomball</city>
        <state>Texas</state>
        <zip>77375</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates of East Texas</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bay Area Total Health Medical Group</name>
      <address>
        <city>Webster</city>
        <state>Texas</state>
        <zip>77598</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Research Institute</name>
      <address>
        <city>Ogden</city>
        <state>Utah</state>
        <zip>84405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jean Brown Research</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alexandria Clinical Research, LLC</name>
      <address>
        <city>Alexandria</city>
        <state>Virginia</state>
        <zip>22304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington Center for Weight Management and Resear</name>
      <address>
        <city>Arlington</city>
        <state>Virginia</state>
        <zip>22201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Burke Internal Medicine and Research</name>
      <address>
        <city>Burke</city>
        <state>Virginia</state>
        <zip>22015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Consultants of Danville, Inc.</name>
      <address>
        <city>Danville</city>
        <state>Virginia</state>
        <zip>24541</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Danville Internal Medicine, Inc</name>
      <address>
        <city>Danville</city>
        <state>Virginia</state>
        <zip>24541</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Heart</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042-1262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seven Corners Medical Research Center</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22044</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>INOVA Health Care Services</name>
      <address>
        <city>Manassas</city>
        <state>Virginia</state>
        <zip>20109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Burke Internal Medicine and Research</name>
      <address>
        <city>Manassas</city>
        <state>Virginia</state>
        <zip>20110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manassas Clinical Research Center</name>
      <address>
        <city>Manassas</city>
        <state>Virginia</state>
        <zip>20110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Research of Hampton Roads - Norfolk, Inc.</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research Associates of Tidewater</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research Partners</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Cardiovascular Specialists</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Clinical Research-Richmond, Inc</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Selma Medical Associates</name>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <zip>22601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Larry D. Stonesifer, MD, Inc PS</name>
      <address>
        <city>Federal Way</city>
        <state>Washington</state>
        <zip>98003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seattle Women's</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rowan Research Inc.</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MultiCare Research Institute</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universal Research Group</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wenatchee Valley Hospital &amp; Clinics</name>
      <address>
        <city>Wenatchee</city>
        <state>Washington</state>
        <zip>98801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates of Bellin Health</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prevea Clinic, Inc</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Investigation Specialists, Inc.</name>
      <address>
        <city>Kenosha</city>
        <state>Wisconsin</state>
        <zip>53142</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meriter hospital Inc., DBA: UnityPoint Health-Meriter Heart</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aspirus Research Institute</name>
      <address>
        <city>Wausau</city>
        <state>Wisconsin</state>
        <zip>54401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coffs Harbour Health Campus</name>
      <address>
        <city>Coffs Harbour</city>
        <state>New South Wales</state>
        <zip>2450</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gosford Hospital, Cardiology Clinical Trials</name>
      <address>
        <city>Gosford</city>
        <state>New South Wales</state>
        <zip>2250</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Liverpool Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>New South Wales</state>
        <zip>2170</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illawarra Shoalhaven Local Health District, Clinical Trial and Research Unit</name>
      <address>
        <city>Wollongong</city>
        <state>New South Wales</state>
        <zip>2500</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wollongong Hospital</name>
      <address>
        <city>Wollongong</city>
        <state>New South Wales</state>
        <zip>2500</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Core Research Group</name>
      <address>
        <city>Brisbane</city>
        <state>Queensland</state>
        <zip>4064</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Princess Alexandra Hospital, Cardiology Research Department</name>
      <address>
        <city>Brisbane</city>
        <state>Queensland</state>
        <zip>4102</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane and Women's Hospital, Endocrinology Department</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <zip>4029</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HeartCare Partners Clinical Research Unit</name>
      <address>
        <city>Milton</city>
        <state>Queensland</state>
        <zip>4064</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AusTrials Pty Ltd</name>
      <address>
        <city>Sherwood</city>
        <state>Queensland</state>
        <zip>4075</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gold Coast Hospital, Cardiovascular Research Centre</name>
      <address>
        <city>Southport</city>
        <state>Queensland</state>
        <zip>4215</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Royal Adelaide Hospital, Cardiology Department</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Adelaide Medical Research</name>
      <address>
        <city>Ashford</city>
        <state>South Australia</state>
        <zip>5035</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lyell McEwin Hospital, Department of Cardiology</name>
      <address>
        <city>Elizabeth Vale</city>
        <state>South Australia</state>
        <zip>5112</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart and Vascular Institute</name>
      <address>
        <city>Fullarton</city>
        <state>South Australia</state>
        <zip>SA 5063</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Queen Elizabeth Hospital</name>
      <address>
        <city>Woodville South</city>
        <state>South Australia</state>
        <zip>5011</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ballarat Health Services</name>
      <address>
        <city>Ballarat</city>
        <state>Victoria</state>
        <zip>3353</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geelong Cardiology Research Unit, Barwon Health</name>
      <address>
        <city>Geelong</city>
        <state>Victoria</state>
        <zip>3220</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Health - Heidelberg Repatriation Hospital, Department of Medicine, Boronia Centre</name>
      <address>
        <city>Heidelberg Heights</city>
        <state>Victoria</state>
        <zip>3081</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Avenue Cardiovascular Centre</name>
      <address>
        <city>Saint Kilda East</city>
        <state>Victoria</state>
        <zip>3183</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Joondalup Cardiovascular Trials Foundation Inc</name>
      <address>
        <city>Joondalup</city>
        <state>Western Australia</state>
        <zip>6027</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fiona Stanley Hospital, Cardiology Research Department,CDO11</name>
      <address>
        <city>Murdoch</city>
        <state>Western Australia</state>
        <zip>6150</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Australian Medical Research Inst, Centre for Clinical Research</name>
      <address>
        <city>Adelaide</city>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Partners Clinical Research Centre</name>
      <address>
        <city>Nassau</city>
        <country>Bahamas</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LMC Clinical Research Inc. (Calgary)</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2H 2G4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gordon and Leslie Diamond Health Care Centre</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nova Scotia Health Authority /QEII Health Sciences Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 3A7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LMC Diabetes &amp; Endocrinology - Brampton</name>
      <address>
        <city>Brampton</city>
        <state>Ontario</state>
        <zip>L6S0C9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McMaster University</name>
      <address>
        <city>Brampton</city>
        <state>Ontario</state>
        <zip>L6Z 4N5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JBN Medical Diagnostic Services Inc.</name>
      <address>
        <city>Burlington</city>
        <state>Ontario</state>
        <zip>L7M 4Y1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aviva Clinical Trial Group In.</name>
      <address>
        <city>Burlington</city>
        <state>Ontario</state>
        <zip>L7R 1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cambridge Cardiac Care Centre</name>
      <address>
        <city>Cambridge</city>
        <state>Ontario</state>
        <zip>N1R 6V6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Joanne F. Liutkus Medicine Professional Corp.</name>
      <address>
        <city>Cambridge</city>
        <state>Ontario</state>
        <zip>N1R 7L6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saul Vizel Professional Medicine Corporation, Vizel Cardiac Research</name>
      <address>
        <city>Cambridge</city>
        <state>Ontario</state>
        <zip>N1R 7R1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LMC Diabetes &amp; Endocrinology (Etobicoke)</name>
      <address>
        <city>Etobicoke</city>
        <state>Ontario</state>
        <zip>M9R4E1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wharton Medical Clinic Clinical Trials Group Inc.</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 5G8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Josephs Health Care London</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4V2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LMC Diabetes &amp; Endocrinoly</name>
      <address>
        <city>Markham</city>
        <state>Ontario</state>
        <zip>L6B0P9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Market Cardiology Research Group</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <zip>L3Y 8C3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Michael Heffernan</name>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <zip>L6K 3W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LMC Clinical Research Inc. (Oakville)</name>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <zip>L6M 4H8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Cha</name>
      <address>
        <city>Oshawa</city>
        <state>Ontario</state>
        <zip>L1J 2K1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Ottawa Heart Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kawartha Cardiology Clinical Trials</name>
      <address>
        <city>Peterborough</city>
        <state>Ontario</state>
        <zip>K9J 0B2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Dinkar Shukla Professional Medicine Corporation</name>
      <address>
        <city>Sudbury</city>
        <state>Ontario</state>
        <zip>P3E 6C3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr Roger Labonte Professional Medicine Corp</name>
      <address>
        <city>Sudbury</city>
        <state>Ontario</state>
        <zip>P3E3B8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LMC Diabetes &amp; Endocrinology (Thornhill)</name>
      <address>
        <city>Thornhill</city>
        <state>Ontario</state>
        <zip>L4J8L7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>JJ DIG Research Ltd.</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M3J 1N2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keele Medical Place</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M3M 3E5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LMC Clinical Research Inc. (Bayview)</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4G 3E8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Michael's Hospital Health Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5C 2T2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ViaCar Recherche Clinique</name>
      <address>
        <city>Brossard</city>
        <state>Quebec</state>
        <zip>J4X 1S4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Q&amp;T Research Outaouais Inc.</name>
      <address>
        <city>Gatineau</city>
        <state>Quebec</state>
        <zip>J8Y 6S8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ViaCar Recherche Clinique Inc.</name>
      <address>
        <city>Greenfield Park</city>
        <state>Quebec</state>
        <zip>J4V 2G8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manna Research Inc</name>
      <address>
        <city>Levis</city>
        <state>Quebec</state>
        <zip>G6W 0M6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Sante Cardio MC</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 3Y7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaire de Cardiologie et de Pneumologie de Quebec</name>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier rgional de Lanaudire</name>
      <address>
        <city>Saint-Charles-Borromee</city>
        <state>Quebec</state>
        <zip>J6E 6J2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Recherche Clinique London</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1J 2E3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CardioVasc HR, Inc.</name>
      <address>
        <city>St Jean sur Richelieu</city>
        <state>Quebec</state>
        <zip>J3A1C3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ViaCar Recherche Clinique Inc.</name>
      <address>
        <city>St-Lambert</city>
        <state>Quebec</state>
        <zip>J4P 2H4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LMC Clinical Research Inc. (Montreal)</name>
      <address>
        <city>Ville Saint-Laurent</city>
        <state>Quebec</state>
        <zip>H4T 1Z9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Biomedica Research Group</name>
      <address>
        <city>Providencia</city>
        <state>Santiago</state>
        <zip>7500710</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sociedad Medica Cardiologica El Llano</name>
      <address>
        <city>San Miguel</city>
        <state>Santiago</state>
        <zip>8910259</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Regional Concepcion</name>
      <address>
        <city>Concepcion</city>
        <zip>4070038</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiocob</name>
      <address>
        <city>Santiago</city>
        <zip>7500520</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Servicios Medicos Godoy Ltda.</name>
      <address>
        <city>Santiago</city>
        <zip>7500710</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ccbr Cecim</name>
      <address>
        <city>Santiago</city>
        <zip>8331143</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Investigacion Clinica del Sur</name>
      <address>
        <city>Temuco</city>
        <zip>4781156</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CECMI Ltda.</name>
      <address>
        <city>Temuco</city>
        <zip>4813299</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ICLE</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44600</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Medical Practice</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44657</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IMED Clin Trials</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo Leon</state>
        <zip>64020</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiolink ClinTrials S.C.</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo Leon</state>
        <zip>64060</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Estudios Clinicos y Especialidades Medicas S.C.</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo Leon</state>
        <zip>64620</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Angeles Xalapa</name>
      <address>
        <city>Xalapa</city>
        <state>Veracruz</state>
        <zip>91193</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacion Cardiovascular de Aguascalientes</name>
      <address>
        <city>Aguascalientes</city>
        <zip>20230</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Cardiologica Aguascalientes</name>
      <address>
        <city>Aguascalientes</city>
        <zip>20230</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mentrials S.A.de C.V.</name>
      <address>
        <city>Distrito Federal</city>
        <zip>06700</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore Hospital-Cardiology Research</name>
      <address>
        <city>Milford</city>
        <state>Auckland</state>
        <zip>0622</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Middlemore Hospital</name>
      <address>
        <city>Papatoetoe</city>
        <state>Auckland</state>
        <zip>2025</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore Hospital - Diabetes Clinic</name>
      <address>
        <city>Takapuna</city>
        <state>Auckland</state>
        <zip>0740</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christchurch Hospital, Lipids</name>
      <address>
        <city>Christchurch</city>
        <state>Canterbury</state>
        <zip>8011</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christchurch Hospital, Cardiology Research</name>
      <address>
        <city>Christchurch</city>
        <state>Canterbury</state>
        <zip>8811</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dunedin Hospital</name>
      <address>
        <city>Dunedin</city>
        <state>Otago</state>
        <zip>9016</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Taranaki Base Hospital</name>
      <address>
        <city>New Plymouth</city>
        <state>Taranaki</state>
        <zip>4310</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hutt Hospital, Cardiology Dept</name>
      <address>
        <city>Lower Hutt</city>
        <state>Wellington</state>
        <zip>5010</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auckland City Hospital</name>
      <address>
        <city>Auckland</city>
        <zip>1148</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hawkes Bay Regional Hospital</name>
      <address>
        <city>Hastings</city>
        <zip>4120</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nelson Hospital, Cardiology Department</name>
      <address>
        <city>Nelson</city>
        <zip>7010</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lakeland Clinical Trials, Rotorua</name>
      <address>
        <city>Rotorua</city>
        <zip>3010</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tauranga Hospital</name>
      <address>
        <city>Tauranga</city>
        <zip>3112</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indywidualna Specjalistyczna Praktyka Lekarska</name>
      <address>
        <city>Bezrzecze</city>
        <zip>72-003</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ &quot;Eskulap&quot;</name>
      <address>
        <city>Biala Rawska</city>
        <zip>96-230</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Podlaski Osrodek Kardiologii Janusz Korecki</name>
      <address>
        <city>Biaystok</city>
        <zip>15-875</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne KERmed</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-231</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>10 Wojskowy Szpital Kliniczny z Poliklinika SPZOZ</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-681</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nzoz &quot;Mada-Med&quot;</name>
      <address>
        <city>Chorzw</city>
        <zip>41-500</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DIABET Centrum Medyczne s. c.</name>
      <address>
        <city>Chrzanw</city>
        <zip>32-500</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ISPL w Dziedzinie Kardiologii lek.med. Krzysztof Cymerman</name>
      <address>
        <city>Gdynia</city>
        <zip>81-157</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ SCBK ProCordis</name>
      <address>
        <city>Gdynia</city>
        <zip>81-423</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gabinet Kardiologiczno-Internistyczny</name>
      <address>
        <city>Gdynia</city>
        <zip>81-472</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praktyka Lekarska dr n. med. Marek Bronisz</name>
      <address>
        <city>Inowroclaw</city>
        <zip>88-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Piotr Mader Diabetic Clinic NZOZ PD-I</name>
      <address>
        <city>Kamieniec Zbkowicki</city>
        <zip>57-230</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ Eskulap SC</name>
      <address>
        <city>Koluszki</city>
        <zip>95-040</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ewa Mirek-Bryniarska Specjalistyczna Praktyka Lekarska</name>
      <address>
        <city>Krakw</city>
        <zip>30-082</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LANDA' Specjalistyczne Gabinety Lekarskie</name>
      <address>
        <city>Krakw</city>
        <zip>31-156</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medyczne Centrum Diabetologiczno Endokrynologiczno</name>
      <address>
        <city>Krakw</city>
        <zip>31-261</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nzoz Cardiamed</name>
      <address>
        <city>Legnica</city>
        <zip>59-220</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;CenterMed Lublin&quot; Sp. z o.o.</name>
      <address>
        <city>Lublin</city>
        <zip>20-044</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indywidualna Praktyka Lekarska</name>
      <address>
        <city>Mrgowo</city>
        <zip>11-700</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zechowicz MEDEUSZ-PLUS</name>
      <address>
        <city>Olsztyn</city>
        <zip>10-010</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praktyka Lekarska Ewa Krzyzagorska</name>
      <address>
        <city>Pozna</city>
        <zip>61-655</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ NEURO-KARD &quot;Ilkowski i Partnerzy&quot;</name>
      <address>
        <city>Pozna</city>
        <zip>61-853</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Specjalistyczna Przychodnia Lekarska MEDIKARD (SPL Medikard)</name>
      <address>
        <city>Pock</city>
        <zip>09-402</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Specjalistyczny Gabinet Lekarski</name>
      <address>
        <city>Tarnw</city>
        <zip>33-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lecznice Citomed Sp. z o.o.</name>
      <address>
        <city>Toru</city>
        <zip>87-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praktyka Lekarska Pawlowicz Lidia</name>
      <address>
        <city>Toru</city>
        <zip>87-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne AMED</name>
      <address>
        <city>Warszawa</city>
        <zip>01-518</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Badawcze Wspolczesnej Terapii</name>
      <address>
        <city>Warszawa</city>
        <zip>02-679</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SNZOZ Fundacji PROCLINICA</name>
      <address>
        <city>Warszawa</city>
        <zip>03-973</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Zdrowia Wierzchoslawice</name>
      <address>
        <city>Wierzchosawice</city>
        <zip>33-122</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regionalna Poradnia Diabetologiczna</name>
      <address>
        <city>Wroclaw</city>
        <zip>50-127</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Specjalistyczne Gabinety Lekarskie &quot;Medicor PLUS&quot;</name>
      <address>
        <city>Wocawek</city>
        <zip>87-800</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ ALL-MED Centrum Medyczne</name>
      <address>
        <city>d</city>
        <zip>94-048</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SP ZOZ w Lecznej</name>
      <address>
        <city>czna</city>
        <zip>21-010</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Bahamas</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>Mexico</country>
    <country>New Zealand</country>
    <country>Poland</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Barbados</country>
    <country>Brazil</country>
    <country>Jamaica</country>
    <country>Puerto Rico</country>
    <country>Russian Federation</country>
    <country>Saint Lucia</country>
    <country>South Africa</country>
    <country>Trinidad and Tobago</country>
  </removed_countries>
  <verification_date>November 2017</verification_date>
  <study_first_submitted>December 18, 2013</study_first_submitted>
  <study_first_submitted_qc>December 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2013</study_first_posted>
  <results_first_submitted>May 14, 2019</results_first_submitted>
  <results_first_submitted_qc>June 27, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 16, 2019</results_first_posted>
  <last_update_submitted>June 27, 2019</last_update_submitted>
  <last_update_submitted_qc>June 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Cardiovascular Disease</keyword>
  <keyword>Multiple Cardiovascular Risk Factors</keyword>
  <keyword>Obesity</keyword>
  <keyword>Overweight</keyword>
  <keyword>MACE</keyword>
  <keyword>Conversion to Diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 30, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT02019264/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 18, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT02019264/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants took part in the study at investigative sites in the United States, Bahamas, Canada, Mexico, Chile, New Zealand, Poland, and Australia from 24 Jan 2014 to 14 May 2018.</recruitment_details>
      <pre_assignment_details>A total of 14,673 participants were screened and enrolled, of which 2673 participants were screen failures and 12,000 were randomized to receive lorcaserin hydrochloride (HCl) or placebo.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
        </group>
        <group group_id="P2">
          <title>Lorcaserin 10 mg</title>
          <description>Participants received lorcaserin HCL 10 milligram (mg), tablets, orally, twice daily for up to 52 months.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6000"/>
                <participants group_id="P2" count="6000"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Safety Analysis Set</title>
              <participants_list>
                <participants group_id="P1" count="5992"/>
                <participants group_id="P2" count="5995"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5752"/>
                <participants group_id="P2" count="5793"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="248"/>
                <participants group_id="P2" count="207"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Not treated</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="142"/>
                <participants group_id="P2" count="117"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Administrative reason</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Missing</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The full analysis (FA) set included all randomized participants regardless of whether they took study drug or not.</population>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
        </group>
        <group group_id="B2">
          <title>Lorcaserin 10 mg</title>
          <description>Participants received lorcaserin HCL 10 mg, tablets, orally, twice daily for up to 52 months.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6000"/>
            <count group_id="B2" value="6000"/>
            <count group_id="B3" value="12000"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.7" spread="8.31"/>
                    <measurement group_id="B2" value="63.5" spread="8.33"/>
                    <measurement group_id="B3" value="63.6" spread="8.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2186"/>
                    <measurement group_id="B2" value="2112"/>
                    <measurement group_id="B3" value="4298"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3814"/>
                    <measurement group_id="B2" value="3888"/>
                    <measurement group_id="B3" value="7702"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="536"/>
                    <measurement group_id="B2" value="502"/>
                    <measurement group_id="B3" value="1038"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5464"/>
                    <measurement group_id="B2" value="5498"/>
                    <measurement group_id="B3" value="10962"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="74"/>
                    <measurement group_id="B2" value="85"/>
                    <measurement group_id="B3" value="159"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="466"/>
                    <measurement group_id="B2" value="454"/>
                    <measurement group_id="B3" value="920"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5331"/>
                    <measurement group_id="B2" value="5309"/>
                    <measurement group_id="B3" value="10640"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="85"/>
                    <measurement group_id="B2" value="96"/>
                    <measurement group_id="B3" value="181"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time From Randomization to First Occurrence of Major Adverse Cardiovascular Events (MACE) at Interim Analysis</title>
        <description>The MACE events involved myocardial infarction (MI), stroke, or cardiovascular (CV) death. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
        <time_frame>Baseline up to Month 42</time_frame>
        <population>The total time analysis set using the intent-to-treat (ITT) set, events were counted that occurred while participants were on and off treatment. Participants with no events were censored at their last study contact or at the visit following sponsor notification of study completion, whichever occurred first.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg</title>
            <description>Participants received lorcaserin HCL 10 mg, tablets, orally, twice daily for up to 52 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomization to First Occurrence of Major Adverse Cardiovascular Events (MACE) at Interim Analysis</title>
          <description>The MACE events involved myocardial infarction (MI), stroke, or cardiovascular (CV) death. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
          <population>The total time analysis set using the intent-to-treat (ITT) set, events were counted that occurred while participants were on and off treatment. Participants with no events were censored at their last study contact or at the visit following sponsor notification of study completion, whichever occurred first.</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6000"/>
                <count group_id="O2" value="6000"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Hazard ratio was based on Cox-regression model including treatment and CV strata as covariates. MACE met non-inferiority when the one-sided upper bound of 97.5% confidence interval of the HR was less than 1.4 (the non-inferiority margin).</non_inferiority_desc>
            <p_value>0.0001</p_value>
            <method>Primary Analytic Method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.005</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.842</ci_lower_limit>
            <ci_upper_limit>1.198</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time From Randomization to First Occurrence of MACE+</title>
        <description>The MACE+ events involved MI, stroke, or CV death or hospitalization for unstable angina or heart failure (HF), or any coronary revascularization. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
        <time_frame>Baseline up to end of study (Month 56)</time_frame>
        <population>The total time analysis set used the ITT set, events were counted that occurred while participants were on and off treatment. Participants with no events were censored at their last study contact or at the visit following Sponsor Notification of Study Completion, whichever occurred first.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg</title>
            <description>Participants received lorcaserin HCL 10 mg, tablets, orally, twice daily for up to 52 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomization to First Occurrence of MACE+</title>
          <description>The MACE+ events involved MI, stroke, or CV death or hospitalization for unstable angina or heart failure (HF), or any coronary revascularization. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
          <population>The total time analysis set used the ITT set, events were counted that occurred while participants were on and off treatment. Participants with no events were censored at their last study contact or at the visit following Sponsor Notification of Study Completion, whichever occurred first.</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6000"/>
                <count group_id="O2" value="6000"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Hazard ratio was based on Cox-regression model including treatment and CV strata as covariates.</non_inferiority_desc>
            <p_value>0.5464</p_value>
            <method>Primary Analytic Method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.969</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.873</ci_lower_limit>
            <ci_upper_limit>1.074</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Randomization to Conversion to Type 2 Diabetes Mellitus (T2DM) for Participants With Prediabetes at Baseline</title>
        <description>Time from randomization to conversion to T2DM was defined as first occurrence of any component of the 2013 American Diabetes Association (ADA) Diagnostic Criteria (ADA, 2013) in participants with prediabetes at baseline. The diagnostic criteria were met if a participant had unequivocal hyperglycemia (random plasma glucose greater than or equal to (&gt;=) 200 milligram per deciliter (mg/dL) (11.1 millimole per liter [mmol/L]) with classic symptoms of hyperglycemia or hyperglycemic crisis) or any of the following criteria were observed and subsequently confirmed on repeat laboratory testing such as: glycosylated hemoglobin (HbA1c) &gt;=to 6.5%; fasting plasma glucose (FPG) &gt;=126 mg/dL (7.0 mmol/L); 2-hour plasma glucose &gt;=200 mg/dL (11.1 mmol/L) by an oral glucose tolerance test (OGTT). The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
        <time_frame>Baseline up to end of study (Month 56)</time_frame>
        <population>Prediabetes and total time analysis set used ITT set: without a history of any type of diabetes and who were prediabetic at baseline; events were counted that occurred while participants were on, off treatment; participants with no events were censored at last study contact/at visit after notification of study completion, whichever occurred first.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg</title>
            <description>Participants received lorcaserin HCL 10 mg, tablets, orally, twice daily for up to 52 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomization to Conversion to Type 2 Diabetes Mellitus (T2DM) for Participants With Prediabetes at Baseline</title>
          <description>Time from randomization to conversion to T2DM was defined as first occurrence of any component of the 2013 American Diabetes Association (ADA) Diagnostic Criteria (ADA, 2013) in participants with prediabetes at baseline. The diagnostic criteria were met if a participant had unequivocal hyperglycemia (random plasma glucose greater than or equal to (&gt;=) 200 milligram per deciliter (mg/dL) (11.1 millimole per liter [mmol/L]) with classic symptoms of hyperglycemia or hyperglycemic crisis) or any of the following criteria were observed and subsequently confirmed on repeat laboratory testing such as: glycosylated hemoglobin (HbA1c) &gt;=to 6.5%; fasting plasma glucose (FPG) &gt;=126 mg/dL (7.0 mmol/L); 2-hour plasma glucose &gt;=200 mg/dL (11.1 mmol/L) by an oral glucose tolerance test (OGTT). The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
          <population>Prediabetes and total time analysis set used ITT set: without a history of any type of diabetes and who were prediabetic at baseline; events were counted that occurred while participants were on, off treatment; participants with no events were censored at last study contact/at visit after notification of study completion, whichever occurred first.</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1976"/>
                <count group_id="O2" value="2015"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Hazard ratio was based on Cox-regression model including treatment as covariate.</non_inferiority_desc>
            <p_value>0.0380</p_value>
            <method>Primary Analytic Method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.807</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.659</ci_lower_limit>
            <ci_upper_limit>0.988</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Randomization to First Occurrence of the Individual Components of MACE+</title>
        <description>The MACE+ events involved MI, stroke, or CV death or hospitalization for unstable angina or HF, or any coronary revascularization. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
        <time_frame>Baseline up to end of study (Month 56)</time_frame>
        <population>The total time analysis set used the ITT set, events counted occurred while participants were on and off treatment. Participants with no events were censored at last study contact or at the visit following Sponsor Notification of Study Completion, whichever first.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg</title>
            <description>Participants received lorcaserin HCL 10 mg, tablets, orally, twice daily for up to 52 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomization to First Occurrence of the Individual Components of MACE+</title>
          <description>The MACE+ events involved MI, stroke, or CV death or hospitalization for unstable angina or HF, or any coronary revascularization. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
          <population>The total time analysis set used the ITT set, events counted occurred while participants were on and off treatment. Participants with no events were censored at last study contact or at the visit following Sponsor Notification of Study Completion, whichever first.</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6000"/>
                <count group_id="O2" value="6000"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>MI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CV death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hospitalization for unstable angina</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HF</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Coronary revascularization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Myocardial Infarction: Hazard ratio was based on Cox-regression model including treatment and CV strata as covariates. 97.5% confidence interval refers to the upper limit of the displayed 2-sided 95% confidence interval.</non_inferiority_desc>
            <p_value>0.0001</p_value>
            <method>Primary Analytic Method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.991</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.824</ci_lower_limit>
            <ci_upper_limit>1.191</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Time to Stroke: Hazard ratio was based on Cox-regression model including treatment and CV strata as covariates. 97.5% CI refers to the upper limit of the displayed 2-sided 95% CI.</non_inferiority_desc>
            <p_value>0.0005</p_value>
            <method>Primary Analytic Method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.856</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.639</ci_lower_limit>
            <ci_upper_limit>1.145</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Cardiovascular Death: Hazard ratio was based on Cox-regression model including treatment and CV strata as covariates. 97.5% confidence interval refers to the upper limit of the displayed 2-sided 95% confidence interval.</non_inferiority_desc>
            <p_value>0.0262</p_value>
            <method>Primary Analytic Method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.045</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.778</ci_lower_limit>
            <ci_upper_limit>1.404</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Hospitalization for Unstable Angina: Hazard ratio was based on Cox-regression model including treatment and CV strata as covariates.</non_inferiority_desc>
            <p_value>0.3243</p_value>
            <method>Primary Analytic Method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.163</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.861</ci_lower_limit>
            <ci_upper_limit>1.571</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Heart Failure: Hazard ratio was based on Cox-regression model including treatment and CV strata as covariates.</non_inferiority_desc>
            <p_value>0.6758</p_value>
            <method>Primary Analytic Method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.952</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.757</ci_lower_limit>
            <ci_upper_limit>1.197</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Coronary Revascularization: Hazard ratio was based on Cox-regression model including treatment and CV strata as covariates.</non_inferiority_desc>
            <p_value>0.7817</p_value>
            <method>Primary Analytic Method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.981</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.856</ci_lower_limit>
            <ci_upper_limit>1.125</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Randomization to Event of All-cause Mortality</title>
        <description>The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
        <time_frame>Baseline up to end of study (Month 56)</time_frame>
        <population>The total time analysis set used the ITT set, events were counted that occurred while participants were on and off treatment. Participants with no events were censored at their last study contact or at the visit following Sponsor Notification of Study Completion, whichever occurred first.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg</title>
            <description>Participants received lorcaserin HCL 10 mg, tablets, orally, twice daily for up to 52 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomization to Event of All-cause Mortality</title>
          <description>The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
          <population>The total time analysis set used the ITT set, events were counted that occurred while participants were on and off treatment. Participants with no events were censored at their last study contact or at the visit following Sponsor Notification of Study Completion, whichever occurred first.</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6000"/>
                <count group_id="O2" value="6000"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Hazard ratio was based on Cox-regression model including treatment and CV strata as covariates.</non_inferiority_desc>
            <p_value>0.4212</p_value>
            <method>Primary Analytic Method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.082</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.893</ci_lower_limit>
            <ci_upper_limit>1.310</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Randomization to Conversion to Normal Glucose Homeostasis in Participants With Prediabetes at Baseline</title>
        <description>Normal glucose homeostasis was defined as HbA1c less than or equal to (&lt;=) 5.6% and FPG &lt; 100 mg/dL without any antidiabetic treatment. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
        <time_frame>Baseline up to end of study (Month 56)</time_frame>
        <population>The prediabetes analysis set included all participants in the ITT set without a history of any type of diabetes and who were prediabetic at baseline.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg</title>
            <description>Participants received lorcaserin HCL 10 mg, tablets, orally, twice daily for up to 52 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomization to Conversion to Normal Glucose Homeostasis in Participants With Prediabetes at Baseline</title>
          <description>Normal glucose homeostasis was defined as HbA1c less than or equal to (&lt;=) 5.6% and FPG &lt; 100 mg/dL without any antidiabetic treatment. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
          <population>The prediabetes analysis set included all participants in the ITT set without a history of any type of diabetes and who were prediabetic at baseline.</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1976"/>
                <count group_id="O2" value="2015"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Hazard ratio was based on a Cox regression model including treatment as covariate.</non_inferiority_desc>
            <p_value>0.1810</p_value>
            <method>Primary Analytic Method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.124</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.947</ci_lower_limit>
            <ci_upper_limit>1.333</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Randomization to Conversion to T2DM for Participants Without Any Type of Diabetes at Baseline</title>
        <description>The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
        <time_frame>Baseline up to end of study (Month 56)</time_frame>
        <population>The nondiabetes analysis set included all participants in the ITT set without a history of any type of diabetes at baseline.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg</title>
            <description>Participants received lorcaserin HCL 10 mg, tablets, orally, twice daily for up to 52 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomization to Conversion to T2DM for Participants Without Any Type of Diabetes at Baseline</title>
          <description>The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
          <population>The nondiabetes analysis set included all participants in the ITT set without a history of any type of diabetes at baseline.</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2569"/>
                <count group_id="O2" value="2615"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Hazard ratio was based on a Cox regression model including treatment as covariate.</non_inferiority_desc>
            <p_value>0.0116</p_value>
            <method>Primary Analytic Method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.773</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.633</ci_lower_limit>
            <ci_upper_limit>0.944</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in HbA1c at Month 6 in Participants With T2DM at Baseline</title>
        <time_frame>Baseline, and Month 6</time_frame>
        <population>The T2DM analysis set included all participants in the ITT set who had T2DM at baseline. The T2DM analysis set where data was available at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg</title>
            <description>Participants received lorcaserin HCL 10 mg, tablets, orally, twice daily for up to 52 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in HbA1c at Month 6 in Participants With T2DM at Baseline</title>
          <population>The T2DM analysis set included all participants in the ITT set who had T2DM at baseline. The T2DM analysis set where data was available at specified time points.</population>
          <units>percentage of HbA1c</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3403"/>
                <count group_id="O2" value="3362"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3403"/>
                    <count group_id="O2" value="3362"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.99" spread="1.066"/>
                    <measurement group_id="O2" value="7.01" spread="1.082"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3087"/>
                    <count group_id="O2" value="3035"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.777"/>
                    <measurement group_id="O2" value="-0.33" spread="0.785"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>P-value was based on analysis of covariance (ANCOVA) model with treatment and stratification variable (presence of established CV disease or CV risk factors without established CV disease) as factors, and baseline HbA1c, as a covariate.</p_value_desc>
            <method>ANCOVA</method>
            <param_type>Least square (LS) Mean Difference (Net)</param_type>
            <param_value>-0.39</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.43</ci_lower_limit>
            <ci_upper_limit>-0.35</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Randomization to Event of New Onset Renal Impairment or Worsening Existing Renal Impairment in All Participants</title>
        <description>New onset/worsening of existing renal impairment was first occurrence of any events: microalbuminuria and macroalbuminuria (albumin-to-creatinine ratio [ACR] &gt;=30mcg/mg and ACR&gt;=300 mcg/mg in spot urine), worsening albuminuria (microalbuminuria at Baseline developed macroalbuminuria, ACR increased &gt;=30% from Baseline during treatment), newly developed chronic kidney disease (CKD) (eGFR &gt;=90 milliliter per minute per 1.73 [mL/min/1.73]body surface area (BSA) and without kidney damage at Baseline changed to CKD Stage 1/higher as per National Kidney Foundation [NKF] Guidelines [2002]) or worsening of CKD (CKD Stage 1/higher as per NKF Guidelines [2002] worsened to higher CKD stages during treatment), or doubling of serum creatinine (creatinine value at least 2 times Baseline value and &gt;=1.5 mg/dL during treatment.), or any of the following: end-stage renal disease, renal transplant, renal death. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
        <time_frame>Baseline up to end of study (Month 56)</time_frame>
        <population>The ITT set included all randomized participants regardless of whether they took study drug or not. This set was the same as the full analysis set.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg</title>
            <description>Participants received lorcaserin HCL 10 mg, tablets, orally, twice daily for up to 52 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomization to Event of New Onset Renal Impairment or Worsening Existing Renal Impairment in All Participants</title>
          <description>New onset/worsening of existing renal impairment was first occurrence of any events: microalbuminuria and macroalbuminuria (albumin-to-creatinine ratio [ACR] &gt;=30mcg/mg and ACR&gt;=300 mcg/mg in spot urine), worsening albuminuria (microalbuminuria at Baseline developed macroalbuminuria, ACR increased &gt;=30% from Baseline during treatment), newly developed chronic kidney disease (CKD) (eGFR &gt;=90 milliliter per minute per 1.73 [mL/min/1.73]body surface area (BSA) and without kidney damage at Baseline changed to CKD Stage 1/higher as per National Kidney Foundation [NKF] Guidelines [2002]) or worsening of CKD (CKD Stage 1/higher as per NKF Guidelines [2002] worsened to higher CKD stages during treatment), or doubling of serum creatinine (creatinine value at least 2 times Baseline value and &gt;=1.5 mg/dL during treatment.), or any of the following: end-stage renal disease, renal transplant, renal death. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
          <population>The ITT set included all randomized participants regardless of whether they took study drug or not. This set was the same as the full analysis set.</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6000"/>
                <count group_id="O2" value="6000"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Hazard ratio was based on Cox-regression model including treatment and CV strata as covariates.</non_inferiority_desc>
            <p_value>0.0054</p_value>
            <method>Primary Analytic Method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.869</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.787</ci_lower_limit>
            <ci_upper_limit>0.959</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Randomization to Event of New Onset Renal Impairment or Worsening Existing Renal Impairment in Participants With Prediabetes at Baseline</title>
        <description>New onset/worsening of existing renal impairment was first occurrence of any events: microalbuminuria and macroalbuminuria (ACR &gt;=30mcg/mg and ACR &gt;=300 mcg/mg in spot urine), worsening albuminuria (microalbuminuria at baseline developed macroalbuminuria, ACR increased &gt;=30% from baseline during treatment), CKD (eGFR &gt;=90 mL/min/1.73 BSA and without kidney damage at baseline changed to CKD Stage 1/higher as per NKF Guidelines [2002]) or worsening of CKD (CKD Stage 1/higher as per NKF Guidelines [2002] worsened to higher CKD stages during treatment), or doubling of serum creatinine (creatinine value at least 2 times baseline value and &gt;=1.5 mg/dL during treatment.), or any of the following: end-stage renal disease, renal transplant, renal death. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
        <time_frame>Baseline up to end of study (Month 56)</time_frame>
        <population>The prediabetes analysis set included all participants in the ITT set without a history of any type of diabetes and who were prediabetic at baseline.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg</title>
            <description>Participants received lorcaserin HCL 10 mg, tablets, orally, twice daily for up to 52 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomization to Event of New Onset Renal Impairment or Worsening Existing Renal Impairment in Participants With Prediabetes at Baseline</title>
          <description>New onset/worsening of existing renal impairment was first occurrence of any events: microalbuminuria and macroalbuminuria (ACR &gt;=30mcg/mg and ACR &gt;=300 mcg/mg in spot urine), worsening albuminuria (microalbuminuria at baseline developed macroalbuminuria, ACR increased &gt;=30% from baseline during treatment), CKD (eGFR &gt;=90 mL/min/1.73 BSA and without kidney damage at baseline changed to CKD Stage 1/higher as per NKF Guidelines [2002]) or worsening of CKD (CKD Stage 1/higher as per NKF Guidelines [2002] worsened to higher CKD stages during treatment), or doubling of serum creatinine (creatinine value at least 2 times baseline value and &gt;=1.5 mg/dL during treatment.), or any of the following: end-stage renal disease, renal transplant, renal death. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
          <population>The prediabetes analysis set included all participants in the ITT set without a history of any type of diabetes and who were prediabetic at baseline.</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1976"/>
                <count group_id="O2" value="2015"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Hazard ratio on a Cox regression model including treatment as covariate.</non_inferiority_desc>
            <p_value>0.3661</p_value>
            <method>Primary Analytic Method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.904</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.727</ci_lower_limit>
            <ci_upper_limit>1.125</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Randomization to Event of New Onset Renal Impairment or Worsening Existing Renal Impairment in Participants With T2DM at Baseline</title>
        <description>New onset/worsening of existing renal impairment was first occurrence of any events: microalbuminuria and macroalbuminuria (ACR &gt;=30 mcg/mg and ACR &gt;=300 mcg/mg in spot urine), worsening albuminuria (microalbuminuria at baseline developed macroalbuminuria, ACR increased &gt;=30% from baseline during treatment), CKD (eGFR &gt;=90 mL/min/1.73 BSA and without kidney damage at baseline changed to CKD Stage 1/higher as per NKF Guidelines [2002]) or worsening of CKD (CKD Stage 1/higher as per NKF Guidelines [2002] worsened to higher CKD stages during treatment), or doubling of serum creatinine (creatinine value at least 2 times baseline value and &gt;=1.5 mg/dL during treatment.), or any of the following: end-stage renal disease, renal transplant, renal death. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
        <time_frame>Baseline up to end of study (Month 56)</time_frame>
        <population>The T2DM analysis set included all participants in the ITT set who had T2DM at baseline.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg</title>
            <description>Participants received lorcaserin HCL 10 mg, tablets, orally, twice daily for up to 52 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomization to Event of New Onset Renal Impairment or Worsening Existing Renal Impairment in Participants With T2DM at Baseline</title>
          <description>New onset/worsening of existing renal impairment was first occurrence of any events: microalbuminuria and macroalbuminuria (ACR &gt;=30 mcg/mg and ACR &gt;=300 mcg/mg in spot urine), worsening albuminuria (microalbuminuria at baseline developed macroalbuminuria, ACR increased &gt;=30% from baseline during treatment), CKD (eGFR &gt;=90 mL/min/1.73 BSA and without kidney damage at baseline changed to CKD Stage 1/higher as per NKF Guidelines [2002]) or worsening of CKD (CKD Stage 1/higher as per NKF Guidelines [2002] worsened to higher CKD stages during treatment), or doubling of serum creatinine (creatinine value at least 2 times baseline value and &gt;=1.5 mg/dL during treatment.), or any of the following: end-stage renal disease, renal transplant, renal death. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
          <population>The T2DM analysis set included all participants in the ITT set who had T2DM at baseline.</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3403"/>
                <count group_id="O2" value="3362"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0082</p_value>
            <method>Primary Analytic Method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.855</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.762</ci_lower_limit>
            <ci_upper_limit>0.960</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Randomization to Event of Improvement in Renal Function in Participants With T2DM at Baseline</title>
        <description>Improvement in renal function was defined as first occurrence of regression of albuminuria or regression of CKD. Regression of albuminuria was defined as when participants with macroalbuminuria at baseline developed microalbuminuria or nonalbuminuria (ACR &lt;30 mcg/mg in spot urine), or participants with microalbuminuria at baseline became nonalbuminuric, and ACR value decreased &gt;= 30% from previous assessment during treatment. Regression of CKD defined as when participants with CKD Stage 1 or higher at baseline improved to normal or lower stages by NKF guidelines (eGFR &gt;=90 with albuminuria at baseline improved to eGFR &gt;=90 without albuminuria, or eGFR 60 to 89 at baseline became eGFR &gt;=90 with or without albuminuria, or eGFR between 30 to 59 at baseline improved to &gt;60 mL/min/1.73 BSA) during treatment. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
        <time_frame>Baseline up to end of study (Month 56)</time_frame>
        <population>The T2DM analysis set included all participants in the ITT set who had T2DM at baseline.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg</title>
            <description>Participants received lorcaserin HCL 10 mg, tablets, orally, twice daily for up to 52 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Randomization to Event of Improvement in Renal Function in Participants With T2DM at Baseline</title>
          <description>Improvement in renal function was defined as first occurrence of regression of albuminuria or regression of CKD. Regression of albuminuria was defined as when participants with macroalbuminuria at baseline developed microalbuminuria or nonalbuminuria (ACR &lt;30 mcg/mg in spot urine), or participants with microalbuminuria at baseline became nonalbuminuric, and ACR value decreased &gt;= 30% from previous assessment during treatment. Regression of CKD defined as when participants with CKD Stage 1 or higher at baseline improved to normal or lower stages by NKF guidelines (eGFR &gt;=90 with albuminuria at baseline improved to eGFR &gt;=90 without albuminuria, or eGFR 60 to 89 at baseline became eGFR &gt;=90 with or without albuminuria, or eGFR between 30 to 59 at baseline improved to &gt;60 mL/min/1.73 BSA) during treatment. The outcome data was assessed using Kaplan-Meier estimate and Greenwood Formula.</description>
          <population>The T2DM analysis set included all participants in the ITT set who had T2DM at baseline.</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3403"/>
                <count group_id="O2" value="3362"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">Median time and 95% confidence interval could not be calculated since quartile was not estimable due to higher number of censored participants.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Hazard ratio was based on Cox-regression model including treatment and CV strata as covariates.</non_inferiority_desc>
            <p_value>0.0297</p_value>
            <method>Primary Analytic Method</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.182</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.017</ci_lower_limit>
            <ci_upper_limit>1.375</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Who Met FDA-Defined Valvulopathy in Echocardiographically Determined Heart Valve Changes</title>
        <time_frame>Months 6 and 12</time_frame>
        <population>The FDA-defined valvulopathy analysis set included all participants in the ITT set without FDA-defined valvulopathy at baseline. The FDA-defined valvulopathy analysis set where data was available at specified time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg</title>
            <description>Participants received lorcaserin HCL 10 mg, tablets, orally, twice daily for up to 52 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Who Met FDA-Defined Valvulopathy in Echocardiographically Determined Heart Valve Changes</title>
          <population>The FDA-defined valvulopathy analysis set included all participants in the ITT set without FDA-defined valvulopathy at baseline. The FDA-defined valvulopathy analysis set where data was available at specified time point.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1935"/>
                <count group_id="O2" value="1925"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Month 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1683"/>
                    <count group_id="O2" value="1681"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4"/>
                    <measurement group_id="O2" value="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1564"/>
                    <count group_id="O2" value="1579"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5"/>
                    <measurement group_id="O2" value="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5015</p_value>
            <p_value_desc>P-value was based on logistic regression including treatment as a factor and baseline body mass index (BMI) as a covariate.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.21</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.69</ci_lower_limit>
            <ci_upper_limit>2.11</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With FDA-Defined Valvulopathy at Baseline Who Demonstrated Worsened FDA-Defined Valvulopathy</title>
        <time_frame>Months 6 and 12</time_frame>
        <population>The ITT analysis set in participants with FDA-defined valvulopathy at baseline was used. The ITT analysis set in participants with FDA-defined valvulopathy at baseline where data was available at specified time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg</title>
            <description>Participants received lorcaserin HCL 10 mg, tablets, orally, twice daily for up to 52 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With FDA-Defined Valvulopathy at Baseline Who Demonstrated Worsened FDA-Defined Valvulopathy</title>
          <population>The ITT analysis set in participants with FDA-defined valvulopathy at baseline was used. The ITT analysis set in participants with FDA-defined valvulopathy at baseline where data was available at specified time point.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="228"/>
                <count group_id="O2" value="225"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Month 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="194"/>
                    <count group_id="O2" value="201"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1"/>
                    <measurement group_id="O2" value="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="180"/>
                    <count group_id="O2" value="189"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7"/>
                    <measurement group_id="O2" value="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7249</p_value>
            <p_value_desc>P-value was based on logistic regression including treatment as a factor and baseline BMI as a covariate.</p_value_desc>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.31</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.29</ci_lower_limit>
            <ci_upper_limit>5.98</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Echocardiographically-Determined Pulmonary Arterial Systolic Pressure</title>
        <time_frame>Baseline, Month 12</time_frame>
        <population>The ITT analysis set-participants in ECHO substudy included all randomized participants regardless of whether they took study drug or not. The ITT analysis set-participants in the ECHO substudy, where data was available at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg</title>
            <description>Participants received lorcaserin HCL 10 mg, tablets, orally, twice daily for up to 52 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Echocardiographically-Determined Pulmonary Arterial Systolic Pressure</title>
          <population>The ITT analysis set-participants in ECHO substudy included all randomized participants regardless of whether they took study drug or not. The ITT analysis set-participants in the ECHO substudy, where data was available at specified time points.</population>
          <units>Millimeter of mercury (mmHg)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2167"/>
                <count group_id="O2" value="2151"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1368"/>
                    <count group_id="O2" value="1358"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.4354" spread="7.66312"/>
                    <measurement group_id="O2" value="26.2029" spread="7.54123"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="882"/>
                    <count group_id="O2" value="893"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6418" spread="6.81716"/>
                    <measurement group_id="O2" value="-0.8223" spread="7.23770"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2976</p_value>
            <p_value_desc>P value was based on a mixed-effects model (unstructured covariance matrix) with repeated measures with treatment, month and treatment by month interaction as factors and baseline pulmonary arterial systolic pressure and baseline BMI as covariates.</p_value_desc>
            <method>Mixed-effects model</method>
            <param_type>Least square (LS) Mean Difference (Net)</param_type>
            <param_value>-0.9036</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.2908</ci_lower_limit>
            <ci_upper_limit>-0.5163</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From baseline up to 30 days after last dose of study drug (approximately 56 months)</time_frame>
      <desc>Adverse events were collected for the participants who were in the safety analysis set (all participants who received at least 1 dose of study drug and had at least one post dose safety assessment).</desc>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Participants received lorcaserin HCL placebo-matching, tablets, orally, twice daily for up to 52 months.</description>
        </group>
        <group group_id="E2">
          <title>Lorcaserin 10 mg</title>
          <description>Participants received lorcaserin HCL 10 milligram (mg), tablets, orally, twice daily for up to 52 months.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (19.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="202" subjects_at_risk="5992"/>
                <counts group_id="E2" subjects_affected="219" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2021" subjects_at_risk="5992"/>
                <counts group_id="E2" subjects_affected="1974" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal lymphadenopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="5992"/>
                <counts group_id="E2" events="14" subjects_affected="12" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Anaemia macrocytic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Autoimmune haemolytic anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Disseminated intravascular coagulation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Microcytic anaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Normochromic normocytic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Splenic haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Splenic infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Spontaneous haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="5992"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Acute left ventricular failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="131" subjects_affected="117" subjects_at_risk="5992"/>
                <counts group_id="E2" events="118" subjects_affected="105" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="136" subjects_affected="123" subjects_at_risk="5992"/>
                <counts group_id="E2" events="152" subjects_affected="142" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" events="115" subjects_affected="106" subjects_at_risk="5992"/>
                <counts group_id="E2" events="129" subjects_affected="113" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Anginal equivalent</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Aortic valve disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Aortic valve incompetence</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Arteriospasm coronary</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="122" subjects_affected="102" subjects_at_risk="5992"/>
                <counts group_id="E2" events="120" subjects_affected="105" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="28" subjects_affected="22" subjects_at_risk="5992"/>
                <counts group_id="E2" events="23" subjects_affected="21" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bradyarrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="17" subjects_affected="17" subjects_at_risk="5992"/>
                <counts group_id="E2" events="18" subjects_affected="18" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bundle branch block bilateral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bundle branch block left</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bundle branch block right</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiac aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="5992"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiac discomfort</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiac disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="25" subjects_affected="21" subjects_at_risk="5992"/>
                <counts group_id="E2" events="19" subjects_affected="18" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="139" subjects_affected="106" subjects_at_risk="5992"/>
                <counts group_id="E2" events="124" subjects_affected="91" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiac perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiac valve disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiac ventricular thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiovascular disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiovascular insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cor pulmonale</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cor pulmonale acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cor pulmonale chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="80" subjects_affected="78" subjects_at_risk="5992"/>
                <counts group_id="E2" events="92" subjects_affected="87" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="10" subjects_affected="8" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Coronary artery perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="5992"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diastolic dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hyperdynamic left ventricle</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypertensive heart disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intracardiac thrombus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Kounis syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Left atrial dilatation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Left ventricular dysfunction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Microvascular coronary artery disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="13" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Mitral valve disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="5992"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Mitral valve prolapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Mitral valve stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="31" subjects_affected="31" subjects_at_risk="5992"/>
                <counts group_id="E2" events="38" subjects_affected="36" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="5992"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pericardial cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pericardial haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pericarditis constrictive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Prinzmetal angina</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pulmonary valve incompetence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pulseless electrical activity</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Sinus node dysfunction</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="17" subjects_affected="15" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Stress cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="5992"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Systolic dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Tricuspid valve incompetence</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ventricular tachyarrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="27" subjects_affected="22" subjects_at_risk="5992"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial septal defect</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Choledochal cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Developmental hip dysplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastrointestinal arteriovenous malformation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypertrophic cardiomyopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Microgenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Tympanic membrane perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="5992"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Thyroid mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Thyrotoxic crisis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Charles Bonnet syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Deformity of orbit</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Macular oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Oscillopsia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Retinal vascular thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vitreous adhesions</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal adhesions</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Abdominal fat apron</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="5992"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Abdominal hernia obstructive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Abdominal incarcerated hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="5992"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Abdominal wall haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Anal fissure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Anal incontinence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Anorectal varices</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Coeliac artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Colitis microscopic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Colonic pseudo-obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Dieulafoy's vascular malformation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diverticular perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Duodenogastric reflux</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Enterocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Erosive duodenitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Erosive oesophagitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Food poisoning</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastric antral vascular ectasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastric disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastric perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastric polyps</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastrointestinal angiodysplasia haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="30" subjects_affected="27" subjects_at_risk="5992"/>
                <counts group_id="E2" events="29" subjects_affected="29" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastrointestinal necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastrointestinal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="5992"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Incarcerated umbilical hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intestinal dilatation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intra-abdominal haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Large intestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Large intestinal ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Megacolon</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Mesenteric artery stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Mesenteric panniculitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Obstruction gastric</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Odynophagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Oesophageal food impaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Oesophageal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Oesophageal spasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Oesophageal stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Oesophageal varices haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Omental infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="5992"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" events="17" subjects_affected="15" subjects_at_risk="5992"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pancreatitis chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pancreatitis relapsing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Peptic ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Rectal polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Salivary gland mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="22" subjects_affected="18" subjects_at_risk="5992"/>
                <counts group_id="E2" events="16" subjects_affected="11" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Tongue disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Uvulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Visceroptosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiac death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="22" subjects_affected="21" subjects_at_risk="5992"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Complication associated with device</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="5992"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Drug withdrawal syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Exercise tolerance decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastrointestinal complication associated with device</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hernia pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Implant site erosion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Incarcerated hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Infusion site extravasation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Localised oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Medical device site haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Multiple organ dysfunction syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="153" subjects_affected="132" subjects_at_risk="5992"/>
                <counts group_id="E2" events="164" subjects_affected="133" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Stent-graft endoleak</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Systemic inflammatory response syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vascular stent occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vascular stent restenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vascular stent thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Autoimmune hepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bile duct obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Biliary dyskinesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="5992"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="5992"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="25" subjects_affected="24" subjects_at_risk="5992"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cholelithiasis obstructive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Chronic hepatic failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cirrhosis alcoholic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cryptogenic cirrhosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Drug-induced liver injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hepatic cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hepatic mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hepatic vascular thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Liver disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Liver injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Non-alcoholic fatty liver</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Portal vein thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Abdominal wall abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Abscess neck</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Abscess of salivary gland</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Anal abscess</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="5992"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Arthritis infective</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bone abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bronchiolitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="26" subjects_affected="26" subjects_at_risk="5992"/>
                <counts group_id="E2" events="19" subjects_affected="18" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bronchitis viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Campylobacter infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Campylobacter sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Catheter site infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="81" subjects_affected="71" subjects_at_risk="5992"/>
                <counts group_id="E2" events="52" subjects_affected="48" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cellulitis pasteurella</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cellulitis staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cellulitis streptococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cholecystitis infective</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Chronic sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Chronic tonsillitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Clostridium difficile infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Colonic abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Dengue fever</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Device related sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diabetic foot infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diabetic gangrene</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diarrhoea infectious</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="22" subjects_affected="17" subjects_at_risk="5992"/>
                <counts group_id="E2" events="26" subjects_affected="23" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Emphysematous cystitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Encephalitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Enterococcal bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Escherichia bacteraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Escherichia infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Escherichia sepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Extradural abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="5992"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastroenteritis bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Groin abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Groin infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>H1N1 influenza</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hepatitis A</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hepatitis B</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Human anaplasmosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Human ehrlichiosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Implant site infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Incision site abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Incision site infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Infectious colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Infectious pleural effusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Infective exacerbation of chronic obstructive airways disease</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Infective tenosynovitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="5992"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Kidney infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Klebsiella bacteraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Labyrinthitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection viral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lyme disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lymphangitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Mastoiditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Necrotising fasciitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Neutropenic sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Oesophageal candidiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="14" subjects_affected="13" subjects_at_risk="5992"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Osteomyelitis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Parainfluenzae virus infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Paraspinal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pelvic abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Perirectal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Peritonitis bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pharyngeal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="90" subjects_affected="86" subjects_at_risk="5992"/>
                <counts group_id="E2" events="105" subjects_affected="92" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pneumonia legionella</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pneumonia mycoplasmal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pneumonia pneumococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pneumonia streptococcal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pneumonia viral</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Post procedural cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Postoperative abscess</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Respiratory moniliasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Respiratory syncytial virus infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Rocky mountain spotted fever</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Rotavirus infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Scrotal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="27" subjects_affected="27" subjects_at_risk="5992"/>
                <counts group_id="E2" events="39" subjects_affected="37" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Sepsis syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Septic arthritis staphylococcal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Septic embolus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Sialoadenitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Staphylococcal bacteraemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Staphylococcal osteomyelitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Staphylococcal skin infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Streptococcal bacteraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Streptococcal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Tooth infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="41" subjects_affected="40" subjects_at_risk="5992"/>
                <counts group_id="E2" events="30" subjects_affected="30" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Urinary tract infection bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Urinary tract infection enterococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vascular stent infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vestibular neuronitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vulvitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>West Nile viral infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Wound abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Wound infection pseudomonas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Wound infection staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Abdominal injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Anaemia postoperative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Anastomotic ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Animal bite</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Arterial bypass thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Arterial injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bladder injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Brain contusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiac contusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiac valve replacement complication</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cartilage injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Chest injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cystitis radiation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Delayed recovery from anaesthesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Extradural haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="17" subjects_affected="15" subjects_at_risk="5992"/>
                <counts group_id="E2" events="21" subjects_affected="21" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Fractured sacrum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastrointestinal stoma complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ilium fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Incarcerated incisional hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Incision site complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Incision site haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Incomplete spinal fusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intentional overdose</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intestinal anastomosis complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Jaw fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Joint capsule rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Joint dislocation postoperative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Kidney contusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Limb traumatic amputation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Liver contusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Mental status changes postoperative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Multiple injuries</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Periprosthetic fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pneumonitis chemical</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pneumothorax traumatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Post laminectomy syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Post procedural bile leak</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Post procedural discharge</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Post procedural haematuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Post procedural myocardial infarction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Post procedural swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Postoperative fever</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Postoperative ileus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Postoperative renal failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Postoperative respiratory failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Postoperative thoracic procedure complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Postoperative wound complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Postpericardiotomy syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Procedural complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Procedural haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Procedural hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Procedural pneumothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pubis fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pulmonary contusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="5992"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Scapula fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Shunt malfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Shunt occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Skin abrasion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Skull fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Splenic rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Stab wound</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Traumatic arthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Traumatic haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Traumatic haemothorax</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Traumatic intracranial haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Urinary retention postoperative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm ruptured</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Weaning failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Wound dehiscence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Wound haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Ammonia increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Aortic bruit</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Blood calcium decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Blood immunoglobulin G decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Blood potassium increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Blood sodium increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Blood urea increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Blood urine present</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Body temperature increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cardiac stress test abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Coagulation test abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>ECG signs of myocardial ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ejection fraction decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Electrocardiogram QT prolonged</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Electrocardiogram ST segment depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Electrocardiogram abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Glycosylated haemoglobin increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Heart rate decreased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>International normalised ratio abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Liver function test abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Liver function test increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>N-terminal prohormone brain natriuretic peptide increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Oxygen saturation decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Platelet count decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Prostatic specific antigen increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Prothrombin time prolonged</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pulmonary arterial pressure increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Troponin T increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Troponin increased</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>White blood cell count increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cholesterosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="21" subjects_affected="21" subjects_at_risk="5992"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="5992"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="7" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hyperosmolar hyperglycaemic state</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hyperosmolar state</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hyperphosphataemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="19" subjects_affected="18" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypophagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lactic acidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="5992"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="5992"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vitamin D deficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="26" subjects_affected="25" subjects_at_risk="5992"/>
                <counts group_id="E2" events="26" subjects_affected="25" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="19" subjects_affected="16" subjects_at_risk="5992"/>
                <counts group_id="E2" events="20" subjects_affected="19" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Arthritis reactive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="5992"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Chondrocalcinosis pyrophosphate</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Exostosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Fibromyalgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Fracture delayed union</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Fracture malunion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Fracture nonunion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gouty arthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Haemarthrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intervertebral disc compression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intervertebral disc displacement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intervertebral disc space narrowing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Limb discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="5992"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Mobility decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Monarthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="5992"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Myositis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Neck mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Neuropathic arthropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="121" subjects_affected="109" subjects_at_risk="5992"/>
                <counts group_id="E2" events="97" subjects_affected="93" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Osteoarthropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Osteolysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pain in jaw</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pathological fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Plantar fasciitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Polymyalgia rheumatica</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Scoliosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Soft tissue mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Spondylitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vertebral foraminal stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vertebral osteophyte</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma gastric</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma of appendix</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma of colon</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Adrenal adenoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Adrenal gland cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Adrenal neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Anal squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Angiomyolipoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Appendix cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Atypical fibroxanthoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma stage III</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Benign gastric neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of ampulla of Vater</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of bladder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of thyroid gland</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Benign renal neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Benign small intestinal neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Biliary neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bladder cancer recurrent</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bone cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bone cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Brain cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="5992"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Breast cancer in situ</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cervix carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cervix carcinoma stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cholangiocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Choroid melanoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Choroid neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Chronic myeloid leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Clear cell renal cell carcinoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Colon cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Colon neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Colorectal adenocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Colorectal cancer stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diffuse large B-cell lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Endometrial adenocarcinoma</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Endometrial cancer</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Extranodal marginal zone B-cell lymphoma (MALT type)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Fibroadenoma of breast</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Fibroma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Follicular thyroid cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastric cancer stage 0</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Gastrointestinal stromal tumour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Glioblastoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Glioblastoma multiforme</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hepatic cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hepatic cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hepatocellular carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hodgkin's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intestinal adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intraductal papillary mucinous neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intraductal papillary-mucinous carcinoma of pancreas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intraductal papilloma of breast</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intraductal proliferative breast lesion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Invasive breast carcinoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Invasive ductal breast carcinoma</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Keratoacanthoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Kidney angiomyolipoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma stage 0</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage III</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma stage II</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" events="21" subjects_affected="17" subjects_at_risk="5992"/>
                <counts group_id="E2" events="24" subjects_affected="20" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Malignant melanoma in situ</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Malignant melanoma stage I</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm of ampulla of Vater</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm of spinal cord</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm of unknown primary site</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Malignant sweat gland neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Melanocytic naevus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Meningioma benign</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Metastases to lymph nodes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Metastasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Metastatic carcinoma of the bladder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Metastatic malignant melanoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Metastatic renal cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Metastatic squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Mucinous cystadenocarcinoma ovary</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Mycosis fungoides</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Myxofibrosarcoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Nasopharyngeal cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Neoplasm prostate</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Neoplasm skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Neuroendocrine carcinoma metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Neuroendocrine tumour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Nodular melanoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer stage I</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Oesophageal adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Oesophageal adenocarcinoma metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Oropharyngeal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ovarian adenoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ovarian cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pancreatic neuroendocrine tumour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Papillary serous endometrial carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Papillary thyroid cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Peritoneal carcinoma metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pharyngeal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pituitary tumour benign</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Plasma cell myeloma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Polycythaemia vera</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" events="51" subjects_affected="51" subjects_at_risk="5992"/>
                <counts group_id="E2" events="50" subjects_affected="50" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Prostate cancer recurrent</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Prostate cancer stage II</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Prostatic adenoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Rectal adenocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Rectal cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Rectosigmoid cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Renal neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Salivary gland adenoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Salivary gland cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Skin squamous cell carcinoma metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Small cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer extensive stage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of head and neck</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of lung</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the oral cavity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the tongue</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm malignant stage unspecified</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Tonsil cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ureteral neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Urethral cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vulval cancer stage 0</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Waldenstrom's macroglobulinaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Amnesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Basal ganglia haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Basal ganglia infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bickerstaff's encephalitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Brain injury</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Brain stem haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Brain stem infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Brain stem stroke</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Carotid artery disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Carotid artery occlusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" events="19" subjects_affected="17" subjects_at_risk="5992"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Carotid sinus syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Central nervous system necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cerebellar infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cerebral circulatory failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cerebrospinal fluid leakage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="42" subjects_affected="41" subjects_at_risk="5992"/>
                <counts group_id="E2" events="31" subjects_affected="29" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cerebrovascular disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cervical cord compression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cervical myelopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cervical radiculopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cervicogenic headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Complex partial seizures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cranial nerve palsies multiple</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cubital tunnel syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Dementia Alzheimer's type</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diabetic coma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="5992"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Embolic cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Facial paralysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Frontal lobe epilepsy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Guillain-Barre syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypertensive encephalopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypoxic-ischaemic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>IIIrd nerve paralysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="5992"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lumbosacral radiculopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Migraine with aura</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Motor neurone disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Myasthenia gravis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Myelomalacia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Myelopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Myoclonus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Nerve root compression</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Neuromyelitis optica spectrum disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Normal pressure hydrocephalus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Parkinsonism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Peripheral sensory neuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Peroneal nerve palsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Petit mal epilepsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="5992"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Radial nerve palsy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Radicular pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="13" subjects_affected="10" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Serotonin syndrome</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Simple partial seizures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Slow speech</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Spinal claudication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Spinal cord disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Spondylitic myelopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Superficial siderosis of central nervous system</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Superior sagittal sinus thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="51" subjects_affected="49" subjects_at_risk="5992"/>
                <counts group_id="E2" events="62" subjects_affected="54" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Thalamus haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Toxic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Transient global amnesia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="39" subjects_affected="38" subjects_at_risk="5992"/>
                <counts group_id="E2" events="55" subjects_affected="46" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Transverse sinus thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Trigeminal neuralgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Unresponsive to stimuli</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>VIth nerve paralysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vertebral artery dissection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vertebral artery thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vocal cord paralysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Device failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Device loosening</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Device pacing issue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lead dislodgement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Anger</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Mental disorder due to a general medical condition</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="12" subjects_affected="10" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Nightmare</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Post-traumatic stress disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Somatic delusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" events="64" subjects_affected="57" subjects_at_risk="5992"/>
                <counts group_id="E2" events="61" subjects_affected="57" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Acute prerenal failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Albuminuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bladder disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bladder dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bladder neck obstruction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bladder necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bladder outlet obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bladder prolapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bladder stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Chronic kidney disease</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cystitis haemorrhagic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diabetic nephropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>End stage renal disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="10" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Haemorrhage urinary tract</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lower urinary tract symptoms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="5992"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Obstructive uropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Oliguria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Renal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Renal infarct</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Renal mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Renal tubular necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ureteral disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ureterocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ureterolithiasis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Urinary bladder haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="9" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Urinary tract obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Acquired hydrocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Adnexa uteri mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" events="12" subjects_affected="10" subjects_at_risk="5992"/>
                <counts group_id="E2" events="11" subjects_affected="7" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Breast enlargement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Breast fibrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Breast hyperplasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Breast pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Breast ulceration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cystocele</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Erectile dysfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Female genital tract fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Mastoptosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Orchitis noninfective</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Organic erectile dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pelvic pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pelvic prolapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Penis disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Postmenopausal haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Priapism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Prostatism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Scrotal haematocoele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Uterine polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Vaginal prolapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="31" subjects_affected="28" subjects_at_risk="5992"/>
                <counts group_id="E2" events="37" subjects_affected="35" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Allergic bronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="11" subjects_affected="9" subjects_at_risk="5992"/>
                <counts group_id="E2" events="15" subjects_affected="12" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bronchial hyperreactivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="53" subjects_affected="43" subjects_at_risk="5992"/>
                <counts group_id="E2" events="58" subjects_affected="39" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Chronic respiratory failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="40" subjects_affected="38" subjects_at_risk="5992"/>
                <counts group_id="E2" events="27" subjects_affected="27" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hiccups</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypercapnia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="5992"/>
                <counts group_id="E2" events="10" subjects_affected="8" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Idiopathic pulmonary fibrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Laryngeal granuloma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Laryngeal mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lung disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Mediastinal haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Mediastinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Nasal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Nasal polyps</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Obstructive airways disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pharyngeal fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pickwickian syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="5992"/>
                <counts group_id="E2" events="13" subjects_affected="12" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pulmonary arterial hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="27" subjects_affected="26" subjects_at_risk="5992"/>
                <counts group_id="E2" events="21" subjects_affected="20" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pulmonary granuloma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pulmonary haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="5992"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="5992"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pulmonary sarcoidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="5992"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Tachypnoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Tonsillar hypertrophy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Dermatitis atopic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diabetic ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Drug reaction with eosinophilia and systemic symptoms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Excessive skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypersensitivity vasculitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Neutrophilic dermatosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Petechiae</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Rash erythematous</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Skin necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Telangiectasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Convalescent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Spousal abuse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated hypertension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Arterial occlusive disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Arterial stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="16" subjects_affected="13" subjects_at_risk="5992"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Dry gangrene</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="19" subjects_affected="14" subjects_at_risk="5992"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypertensive emergency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="5992"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Iliac artery disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Ischaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Leriche syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Lymphoedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Malignant hypertension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Microscopic polyangiitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="5992"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Peripheral artery dissection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Peripheral artery occlusion</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Peripheral artery stenosis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="4" subjects_at_risk="5992"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Peripheral artery thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="5992"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Peripheral venous disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Poor peripheral circulation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Reperfusion injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Shock haemorrhagic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Subclavian artery stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Subclavian vein thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis superficial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="5992"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Venous thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Venous thrombosis limb</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="5992"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (19.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4788" subjects_at_risk="5992"/>
                <counts group_id="E2" subjects_affected="4946" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="268" subjects_affected="248" subjects_at_risk="5992"/>
                <counts group_id="E2" events="362" subjects_affected="336" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="362" subjects_affected="324" subjects_at_risk="5992"/>
                <counts group_id="E2" events="478" subjects_affected="419" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="329" subjects_affected="286" subjects_at_risk="5992"/>
                <counts group_id="E2" events="398" subjects_affected="356" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="329" subjects_affected="302" subjects_at_risk="5992"/>
                <counts group_id="E2" events="548" subjects_affected="496" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="385" subjects_affected="340" subjects_at_risk="5992"/>
                <counts group_id="E2" events="294" subjects_affected="267" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="584" subjects_affected="468" subjects_at_risk="5992"/>
                <counts group_id="E2" events="536" subjects_affected="455" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="418" subjects_affected="338" subjects_at_risk="5992"/>
                <counts group_id="E2" events="426" subjects_affected="353" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="690" subjects_affected="567" subjects_at_risk="5992"/>
                <counts group_id="E2" events="659" subjects_affected="528" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="575" subjects_affected="400" subjects_at_risk="5992"/>
                <counts group_id="E2" events="593" subjects_affected="440" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="542" subjects_affected="452" subjects_at_risk="5992"/>
                <counts group_id="E2" events="544" subjects_affected="457" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="496" subjects_affected="452" subjects_at_risk="5992"/>
                <counts group_id="E2" events="496" subjects_affected="457" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="407" subjects_affected="340" subjects_at_risk="5992"/>
                <counts group_id="E2" events="640" subjects_affected="537" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="316" subjects_affected="274" subjects_at_risk="5992"/>
                <counts group_id="E2" events="445" subjects_affected="383" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="351" subjects_affected="303" subjects_at_risk="5992"/>
                <counts group_id="E2" events="431" subjects_affected="376" subjects_at_risk="5995"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="347" subjects_affected="310" subjects_at_risk="5992"/>
                <counts group_id="E2" events="312" subjects_affected="285" subjects_at_risk="5995"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Eisai Medical Information</name_or_title>
      <organization>Eisai Ltd</organization>
      <phone>+1-888-274-2378</phone>
      <email>esi_medinfo@eisai.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

